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ABSTRACT 27 
 28 
Non-centrosomal microtubule organizing centers (MTOCs) are important for microtubule 29 
organization in many cell types. In fission yeast Schizosaccharomyces pombe, the protein 30 
Mto1, together with partner protein Mto2 (Mto1/2 complex), recruits the -tubulin complex to 31 
multiple non-centrosomal MTOCs, including the nuclear envelope (NE). Here, we develop a 32 
comparative-interactome mass spectrometry approach to determine how Mto1 localizes to 33 
the NE. Surprisingly, we find that Mto1, a constitutively cytoplasmic protein, docks at nuclear 34 
pore complexes (NPCs), via interaction with exportin Crm1 and cytoplasmic FG-nucleoporin 35 
Nup146. Although Mto1 is not a nuclear export cargo, it binds Crm1 via a nuclear export 36 
signal-like sequence, and docking requires both Ran in the GTP-bound state and Nup146 37 
FG repeats. In addition to determining the mechanism of MTOC formation at the NE, our 38 
results reveal a novel role for Crm1 and the nuclear export machinery in the stable docking 39 
of a cytoplasmic protein complex at NPCs.  40 
 3 
INTRODUCTION 41 
Non-centrosomal microtubule organizing centers (MTOCs) are critical to the morphology 42 
and function of many types of cells (Petry & Vale, 2015, Sanchez & Feldman, 2017, Wu & 43 
Akhmanova, 2017), especially cells in which interphase microtubules (MTs) are arranged in 44 
linear rather than radial arrays (Bartolini & Gundersen, 2006). Examples include 45 
differentiated animal cells such as neurons (Kapitein & Hoogenraad, 2015), muscle 46 
(Mogessie et al., 2015, Tassin et al., 1985), and epithelial cells (Wu & Akhmanova, 2017), 47 
and many higher plant cells (Masoud et al., 2013, Oda, 2015), as well as some single-celled 48 
eukaryotes, such as fission yeast Schizosaccharomyces pombe (Chang & Martin, 2009, 49 
Sawin & Tran, 2006). 50 
The mechanisms underlying non-centrosomal MTOC formation are just beginning to be 51 
understood. Some non-centrosomal MTs are thought to be generated by nucleation-and-52 
release from the centrosome, followed by minus-end stabilization and anchoring elsewhere 53 
in the cell (Bartolini & Gundersen, 2006, Sanchez & Feldman, 2017, Wu & Akhmanova, 54 
2017). However, in many cases MTs are nucleated directly from non-centrosomal sites by 55 
the -tubulin complex, the primary microtubule-nucleation complex in eukaryotic cells 56 
(Kollman et al., 2011, Petry & Vale, 2015). Understanding how the -tubulin complex is 57 
recruited to these sites is thus key to deciphering the fundamental mechanisms of non-58 
centrosomal MT organization (Lin et al., 2015).   59 
Sites of non-centrosomal -tubulin complex recruitment include pre-existing 60 
microtubules themselves, as well as membrane-bound compartments such as the Golgi 61 
apparatus and the nuclear envelope (NE). Recruitment of the -tubulin complex to pre-62 
existing microtubules depends on the multi-subunit augmin complex, in both animals and 63 
plants (Goshima et al., 2008, Liu et al., 2014, Sanchez-Huertas et al., 2016). Microtubule 64 
nucleation and organization by the Golgi apparatus is orchestrated largely by AKAP450, 65 
which recruits not only the -tubulin complex but also its activators, as well as MT minus-end 66 
stabilizers (Rivero et al., 2009, Wu et al., 2016). Combined recruitment of -tubulin complex 67 
and MT minus-end stabilizers/anchoring proteins is also important for MTOC organization at 68 
the cell cortex in diverse types of epithelial cells (summarized in (Sanchez & Feldman, 2017, 69 
Wu & Akhmanova, 2017)). 70 
MTOC formation at the NE remains poorly understood. The NE is an important MT 71 
nucleation site both in muscle cells (Tassin et al., 1985) and in higher plants (Ambrose & 72 
Wasteneys, 2014, Masoud et al., 2013, Stoppin et al., 1994), as well as in fission yeast 73 
(Lynch et al., 2014, Sawin & Tran, 2006). In muscle, -tubulin complex components and 74 
associated proteins are redistributed from the centrosome to the NE during 75 
development/differentiation, coincident with a decrease in centrosomal MT nucleation and 76 
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large-scale changes in intracellular MT organization (Bugnard et al., 2005, Fant et al., 2009, 77 
Srsen et al., 2009, Zebrowski et al., 2015).  In plant cells, which lack centrosomes 78 
altogether, many of the same proteins are similarly observed on the NE, especially before 79 
and/or after cell division (Erhardt et al., 2002, Janski et al., 2012, Nakamura et al., 2012, 80 
Seltzer et al., 2007). However, the mechanisms that regulate their recruitment are largely a 81 
mystery. 82 
Fission yeast nucleate MTs from multiple non-centrosomal sites through the cell cycle 83 
and thus provide an excellent system to study non-centrosomal MTOCs, including those on 84 
the NE (Sawin & Tran, 2006). During interphase, linear arrays of MTs are nucleated from the 85 
spindle pole body (SPB; the yeast centrosome equivalent), from MTOCs on the NE and on 86 
pre-existing microtubules, and from “free” MTOCs in the cytoplasm. As cells enter mitosis, 87 
non-centrosomal MT nucleation is switched off (Borek et al., 2015) and the duplicated SPBs 88 
become the only active MTOCs, nucleating both intranuclear spindle MTs and cytoplasmic 89 
astral MTs. Towards the end of cell division, microtubules are nucleated from the cytokinetic 90 
actomyosin ring (CAR). By contrast, in budding yeast Saccharomyces cerevisiae, the SPBs 91 
are the only MTOCs throughout the cell cycle. 92 
In fission yeast, all MT nucleation in the cytoplasm (i.e. both centrosomal and non-93 
centrosomal nucleation) depends on the Mto1/2 complex (Janson et al., 2005, Samejima et 94 
al., 2005, Sawin et al., 2004, Venkatram et al., 2005, Venkatram et al., 2004). Mto1/2 95 
contains multiple copies of the proteins Mto1 and Mto2 and directly recruits the -tubulin 96 
complex to prospective MTOC sites. Mto1/2 interacts with the -tubulin complex via Mto1’s 97 
Centrosomin Motif 1 (CM1) domain, which is conserved in higher eukaryotic MTOC 98 
regulators such as Drosophila centrosomin, and human CDK5RAP2 and myomegalin 99 
(Samejima et al., 2008, Sawin et al., 2004, Zhang & Megraw, 2007). Interaction of CM1-100 
domain proteins with the -tubulin complex can also serve to activate the -tubulin complex 101 
(Choi et al., 2010, Lynch et al., 2014), although the detailed mechanisms remain unclear. 102 
Because Mto1/2 localizes to prospective MTOC sites independently of interacting with 103 
the -tubulin complex (Samejima et al., 2008), Mto1/2 localization effectively determines 104 
where and when all cytoplasmic MTOCs are generated, and thus understanding Mto1/2 105 
localization is critical to understanding MTOC formation more broadly. Mto1/2 localization is 106 
mediated primarily by domains within Mto1 (Fig. 1A; (Samejima et al., 2010)), although Mto2 107 
contributes indirectly by helping to multimerize the Mto1/2 complex (Lynch et al., 2014, 108 
Samejima et al., 2005). Mto1/2 association with pre-existing MTs depends on a broadly 109 
defined region near the Mto1 C-terminus, while localization to the CAR and the SPB is 110 
mediated by overlapping modular sequences within the conserved MASC domain at the 111 
Mto1 C-terminus (Samejima et al., 2010). Localization to the CAR involves interaction of 112 
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MASC with the unconventional myosin Myp2, while localization to the SPB involves the 113 
Septation Initiation Network protein Cdc11 (Samejima et al., 2010). 114 
Here we determine the mechanism of Mto1/2 localization to the NE. Using a 115 
comparative-interactome mass spectrometry approach, we find that NE localization depends 116 
on the Mto1 N-terminus interacting with exportin Crm1, a nuclear transport receptor, and 117 
nucleoporin Nup146, a component of the nuclear pore complex (NPC). We further find that 118 
although Mto1 is an exclusively cytoplasmic protein, it becomes stably docked at the NPC by 119 
mimicking a nuclear export cargo. In addition to revealing the mechanism of MTOC 120 
formation at the fission yeast NE, our work demonstrates a completely novel role for the 121 
nuclear export machinery, in which the exportin is repurposed to create NPC-docking sites 122 
for cytoplasmic proteins with functions unrelated to nuclear export. 123 
 124 
RESULTS 125 
MT nucleation from the NE contributes to nuclear positioning 126 
Mto1 localization to the NE is enhanced in the C-terminal truncation mutant Mto1[NE], 127 
which lacks MASC and MT-localization domains ((Lynch et al., 2014); Fig. 1A). Previously 128 
we deleted amino acids 1-130 from Mto1[NE] and from full-length Mto1 to make 129 
Mto1[bonsai] and Mto1[∆130], respectively (Fig. 1A), and we showed that these deletions 130 
lead to loss of Mto1/2 complex from the NE, accompanied by loss of MT nucleation from the 131 
NE (Lynch et al., 2014). However, in that work the consequences of this altered MT 132 
nucleation were not investigated. In fission yeast, MT-dependent pushing forces are thought 133 
to center the interphase nucleus precisely in the cell middle (Tran et al., 2001). Because 134 
nuclear position during early mitosis determines the future cell division plane, this ensures 135 
equal size of daughter cells after cell division (Daga & Chang, 2005). To investigate whether 136 
MT nucleation from the NE contributes to nuclear positioning, we measured interphase 137 
nuclear position in mto1-GFP, mto1[NE]-GFP, mto1[∆130-GFP] and mto1[bonsai]-GFP cells 138 
(Fig. 1A; Fig. 1—figure supplement 1). (In these and all subsequent experiments, mto1 139 
mutants replace endogenous wild-type mto1+ at the mto1 locus, and in this particular 140 
experiment, all versions of mto1 were GFP-tagged to equalize protein expression levels 141 
(Lynch et al., 2014)). Interestingly, nuclear positioning was less accurate in mto1[bonsai]-142 
GFP and mto1[∆130]-GFP cells compared to mto1[NE]-GFP and mto1-GFP cells, indicating 143 
that MT nucleation from the NE contributes to nuclear positioning. By contrast, there was no 144 
difference in nuclear positioning between wild-type and mto1[NE] cells, or between 145 
mto1[131-1115] and mto1[bonsai] cells, indicating that MT nucleation from the SPB is not 146 
particularly important for nuclear positioning. 147 
 148 
Identification of proteins interacting with Mto1[NE] but not with Mto1[bonsai] 149 
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To identify proteins involved in recruiting Mto1 to the NE, we wanted to compare 150 
interactomes of Mto1[NE] vs. Mto1[bonsai]. Initially we attempted to use SILAC mass 151 
spectrometry (MS) (Bicho et al., 2010, Ong et al., 2002) to compare anti-GFP 152 
immunoprecipitates of Mto1[9A1-NE]-GFP and Mto1[9A1-bonsai]-GFP, which are otherwise 153 
identical to Mto1[NE]-GFP and Mto1[bonsai]-GFP except for the additional mutation of nine 154 
consecutive amino acids in the CM1 domain to alanine (Samejima et al., 2008), Fig 1A); the 155 
9A1 mutation disrupts interaction with the -tubulin complex and thereby enhances 156 
localization of Mto1[NE] to the NE ((Lynch et al., 2014); Fig. 1—figure supplement 2). In 157 
preliminary experiments, however, we found that the immunoprecipitation approach yielded 158 
low peptide counts for many Mto1-interactors of potential interest (Suppl. File 2). We 159 
therefore decided to develop a more robust method to capture interactors even when they 160 
may be low-abundance and/or low-affinity interactors. 161 
We tagged Mto1[9A1-NE] and Mto1[9A1-bonsai] at their N-termini with GFP and at their 162 
C-termini with an HTB (His-TEV-biotin) tag, which allows for two-step purification of a tagged 163 
protein under fully denaturing conditions after cross-linking to interactors (Tagwerker et al., 164 
2006) (Fig. 1B). As expected, GFP-Mto1[9A1-NE]-HTB localized to the NE in vivo, while 165 
GFP-Mto1[9A1-bonsai]-HTB was present only in the cytoplasm (Fig. 1C). Disuccinimidyl 166 
suberate (DSS) cross-linking of cell cryogrindates shifted a significant proportion of HTB-167 
tagged Mto1 into higher molecular-weight species (Fig. 1D). After DSS cross-linking and 168 
denaturing purification (Fig. 1E; see Materials and Methods), we analyzed cross-linked 169 
adducts of GFP-Mto1[9A1-NE]-HTB and GFP-Mto1[9A1-bonsai]-HTB by label-free 170 
quantification (LFQ) MS ((Cox & Mann, 2008, Tyanova et al., 2016); Fig. 1F; Table 1; Suppl. 171 
File 3).  Among the proteins significantly enriched in the Mto1[9A1-NE] interactome vs. the 172 
Mto1[9A1-bonsai] interactome, we identified nucleoporin Nup146 (Asakawa et al., 2014, 173 
Chen et al., 2004), exportin Crm1 (Adachi & Yanagida, 1989, Fung & Chook, 2014, Hutten & 174 
Kehlenbach, 2007, Stade et al., 1997), the fission yeast TACC homolog, Alp7 (Sato et al., 175 
2004), and, to a lesser extent, polo kinase Plo1 (Ohkura et al., 1995). 176 
Neither Alp7 nor Plo1 is known to localize to the NE, and Plo1 was not investigated 177 
further. The interaction of Mto1[NE] with Alp7 was of potential interest because of the role of 178 
Alp7 in microtubule organization (Ling et al., 2009, Sato et al., 2009, Zheng et al., 2006), and 179 
an interaction between Mto1 and Alp7 has been confirmed independently (M. Sato, Waseda 180 
University, personal communication, July 2017). However, we found that in alp7∆ deletion 181 
mutants, Mto1[9A1-NE]-GFP was present on the NE just as in wild-type (alp7+) cells (Fig. 182 
1—figure supplement 3). This indicates that Alp7 is not required for Mto1 localization to the 183 
NE.   184 
 185 
Mto1[NE] associates with the cytoplasmic face of the NPC 186 
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The interaction of Mto1[9A1-NE] with Nup146 suggested that Mto1 may localize to 187 
nuclear pore complexes (NPCs) on the NE. We therefore imaged Mto1[9A1-NE]-GFP 188 
together with Nup146-3mCherry in a nup132∆ background, in which NPCs can become 189 
clustered on the NE (Bai et al., 2004). We observed extensive colocalization of Mto1[9A1-190 
NE]-GFP with Nup146-3mCherry clusters (Fig. 2A), indicating specific association with 191 
NPCs. 192 
We also examined Mto1[9A1-NE]-GFP localization by immunoelectron microscopy. 193 
Close homologs of Nup146 in budding yeast (Nup159; referred to here as Sc Nup159) and 194 
humans (Nup214; referred to as Hs Nup214) are both located exclusively at the cytoplasmic 195 
face of NPCs (Gorsch et al., 1995, Kraemer et al., 1994, Kraemer et al., 1995), and indirect 196 
evidence suggests that this is also the case for Nup146 (Lo Presti et al., 2012). Consistent 197 
with this, we observed Mto1[9A1-NE]-GFP specifically at the cytoplasmic face of NPCs (Fig. 198 
2B). 199 
 200 
Mto1 localization to NPCs requires export cargo-binding activity of exportin Crm1 201 
The interaction of Mto1[NE] with Crm1 was both surprising and puzzling. As the major 202 
transport receptor for nuclear export of proteins (as well as some RNAs), Crm1 normally 203 
forms a trimeric complex with export cargo and RanGTP within the nucleus, which facilitates 204 
transit of cargo through the permeability barrier of the NPC and into the cytoplasm (Dong et 205 
al., 2009, Fung & Chook, 2014, Hutten & Kehlenbach, 2007). However, to date there is no 206 
evidence that Mto1 is a nuclear export cargo or indeed is ever present in the nucleus. 207 
Because deletion of crm1+ is lethal (Adachi & Yanagida, 1989), we investigated the 208 
significance of the Mto1-Crm1 interaction by asking whether inhibition of Crm1 cargo-binding 209 
activity affects Mto1 localization to NPCs. Nuclear export cargos typically bind to Crm1 via 210 
hydrophobic nuclear export signals (NESs) (Dong et al., 2009, Fung & Chook, 2014, Fung et 211 
al., 2015, Guttler et al., 2010, Hutten & Kehlenbach, 2007, Kutay & Guttinger, 2005). This 212 
can be inhibited by the drug leptomycin B (LMB), which binds within the hydrophobic NES-213 
binding cleft of Crm1 ((Dong et al., 2009, Fornerod et al., 1997a, Fukuda et al., 1997, Fung 214 
& Chook, 2014, Ossareh-Nazari et al., 1997). As a result, when cells are treated with LMB, 215 
nuclear export cargos accumulate within the nucleus. Interestingly, after LMB treatment, we 216 
found that Mto1[9A1-NE]-GFP was lost from NPCs (Fig. 3A). Strikingly, however, rather than 217 
accumulating in the nucleus, Mto1[9A1-NE]-GFP became dispersed in the cytoplasm. 218 
Given the unusual behavior of Mto1[9A1-NE]-GFP after LMB treatment, we confirmed 219 
that LMB was inhibiting nuclear export. We assayed localization of Alp7, which shuttles 220 
continuously in and out of the nucleus during interphase, in complex with its partner protein 221 
Alp14 (ch-TOG homolog) (Okada & Sato, 2015, Okada et al., 2014)(Fig. 3—figure 222 
supplement 1). In the absence of LMB, Alp7-3GFP was present in the cytoplasm, primarily 223 
 8 
as puncta on cytoplasmic MTs. As expected, after LMB treatment, Alp7-3GFP accumulated 224 
in the nucleoplasm and on an intranuclear MT bundle that has been described to form upon 225 
LMB treatment of fission yeast (Matsuyama et al., 2006)(Fig. 3—figure supplement 1). 226 
To rule out the possibility that loss of Mto1[9A1-NE]-GFP from NPCs was due to an off-227 
target effect of LMB (i.e., unrelated to Crm1 inhibition), we generated an LMB-resistant crm1 228 
mutant. LMB is a particularly potent inhibitor of Crm1 because it reacts covalently with 229 
cysteine 529 (C529) in Crm1’s NES-binding cleft (Kudo et al., 1999). We mutated C529 in 230 
the endogenous crm1 coding sequence to alanine (crm1-C529A), as well as to serine (crm1-231 
C529S), threonine (crm1-C529T) and valine (crm1-C529V) (Fig. 3B, Fig. 3—figure 232 
supplement 2). All four mutants were viable, indicating that they preserve essential functions 233 
of crm1 for nuclear export, and three out of the four were resistant to high concentrations of 234 
LMB (Fig. 3—figure supplement 2A). Interestingly, we found that in crm1-C529A cells, 235 
Mto1[9A1-NE]-GFP localized to NPCs both in the absence and in the presence of LMB (Fig. 236 
3B). This demonstrates that loss of Mto1 from NPCs after LMB treatment can be specifically 237 
attributed to inhibition at the Crm1 cargo-binding cleft. 238 
In addition to these experiments, we used immunofluorescence to compare MT 239 
regrowth after cold-induced MT depolymerization in control vs. LMB-treated wild-type cells 240 
(i.e. cells expressing full-length, untagged Mto1). Previous work showed that cold-induced 241 
MT depolymerization causes the pool of Mto1 normally associated with cytoplasmic MTs to 242 
redistribute to the NE, and as a result, when cells are rewarmed, nearly all MT regrowth 243 
initiates from the NE (Sawin et al., 2004). As expected, we found that in control cells, MT 244 
regrowth occurred from the NE. However, in LMB-treated cells, MT regrowth occurred 245 
randomly in the cytoplasm, consistent with a failure of Mto1 to localize to the NE after LMB 246 
treatment (Fig. 3—figure supplement 3). 247 
 248 
Mto1 interacts with Crm1 via a nuclear export signal-like sequence 249 
How might Crm1 cargo-binding activity be involved in Mto1 localization to the NPC? We 250 
hypothesized that Mto1 itself might bind to Crm1 as an unconventional “cargo” and 251 
somehow exploit this interaction to localize to the cytoplasmic face of the NPC. To test this, 252 
we used LFQ MS to compare GFP-Mto1[9A-NE]-HTB interactomes prepared from untreated 253 
vs. LMB-treated cells (Fig. 3C; Table 2; Suppl. File 4). Interestingly, only 3-4 out of nearly 254 
500 quantified proteins were significantly enriched in the GFP-Mto1[9A1-NE]-HTB 255 
interactome from untreated cells compared to LMB-treated cells. Among these, Crm1 256 
showed the greatest enrichment (~20X). Nup146 also showed enrichment, but to a lesser 257 
extent (~2.8X), which may indicate that Mto1 can bind weakly to Nup146 independently of 258 
Crm1 (see Discussion). These results demonstrate that, like Mto1 localization to NPCs, 259 
Mto1 interaction with Crm1 requires Crm1 cargo-binding activity.  260 
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Based on these findings, we next used the LocNES algorithm (Xu et al., 2015) to search 261 
for NES-like sequences within the N-terminal 130 amino acids of Mto1, which are present in 262 
Mto1[NE] but absent from Mto1[bonsai]. The sequence spanning Mto1 amino acids 9-25 263 
contained two closely overlapping candidate NESs (Fig. 4A). Interestingly, the spacing of 264 
hydrophobic amino acids within this NES-like sequence is similar to that of several non-265 
natural high-affinity NESs (Fig. 4B; (Engelsma et al., 2004, Guttler et al., 2010)). 266 
To investigate the role of the Mto1 NES-like sequence, we deleted the first 25 amino 267 
acids of Mto1 from GFP-Mto1[9A1-NE]-HTB. The truncated protein, termed GFP-268 
Mto1[∆NES-9A1-NE]-HTB, failed to localize to NPCs and instead was present in the 269 
cytoplasm (Fig. 4C). In parallel, we used LFQ MS to determine how the ∆NES truncation 270 
affected the GFP-Mto1[9A1-NE]-HTB interactome. As with LMB treatment, very few proteins 271 
were enriched in the GFP-Mto1[9A1-NE]-HTB interactome compared to GFP-Mto1[∆NES-272 
9A1-NE]-HTB interactome (Fig. 4D; Table 3; Suppl. File 5). However, we observed strong 273 
enrichment of both Crm1 (~85X) and Nup146 (~20X). The importance of the Mto1 NES-like 274 
sequence both for localization to NPCs and for interaction with Crm1 strongly suggests that 275 
Mto1 is a direct but unconventional cargo for Crm1. Because of the unusual role of the Mto1 276 
NES-like sequence, we will refer to it as a “NES-mimic” (NES-M). 277 
 278 
The Mto1 NES-mimic is sufficient for nuclear envelope localization  279 
We next asked whether the Mto1 NES-M is sufficient to localize a reporter protein to the 280 
NPC. We replaced endogenous Mto1 with GFP-Mto1[1-29]-GST, which contains only the 281 
first 29 amino acids of Mto1. Strikingly, GFP-Mto1[1-29]-GST localized to puncta on the NE, 282 
which we interpret to be NPCs (Fig.4E). By contrast, GFP-Mto1[1-12]-GST, which lacks the 283 
NES-M, did not show any specific localization. We further found that after LMB treatment, 284 
GFP-Mto1[1-29]-GST was lost from NPCs (Fig. 4F); moreover, like Mto1[9A1-NE]-GFP, 285 
GFP-Mto1[1-29]-GST was present exclusively in the cytoplasm after LMB treatment. 286 
Compared to GFP fusions with Mto1[NE], GFP-Mto1[1-29]-GST had a weaker punctate 287 
localization at NPCs. We hypothesized that this may be due an avidity effect, because 288 
Mto1[NE] can form higher-order multimers, via its coiled-coil region and via interaction with 289 
Mto2 (Lynch et al., 2014), whereas GFP-Mto1[1-29]-GST would be expected to form only 290 
dimers, via the GST domain. To investigate whether dimerization may contribute to NPC 291 
localization, we analyzed localization of a GFP-Mto1[1-29]-13Myc fusion protein, which 292 
should be monomeric. GFP-Mto1[1-29]-13Myc did not localize to NPCs (Fig. 4E), suggesting 293 
that dimerization/multimerization may be an important factor for Mto1 NPC localization. 294 
Collectively, these results indicate the Mto1 NES-M is both necessary and sufficient for 295 
localization to NPCs, without ever being present in the nucleus.  296 
 297 
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Mto1 NPC localization requires RanGTP 298 
To further investigate similarities between the mechanism of Mto1 localization to NPCs 299 
and nuclear export, we tested whether Mto1 localization depends on the nucleotide state of 300 
Ran. Net directional transport of conventional cargos through the NPC depends on a 301 
RanGTP gradient across the NE, generated by Ran GTPase activating protein (RanGAP) in 302 
the cytoplasm and Ran guanine-nucleotide exchange factor (RanGEF) in the nucleus 303 
(Aitchison & Rout, 2012, Gorlich & Kutay, 1999, Wente & Rout, 2010). Importins bind import 304 
cargos in the cytoplasm, where RanGTP concentration is low, and release them in the 305 
nucleus, where RanGTP concentration is high. By contrast, exportins bind cooperatively to 306 
export cargos and RanGTP within the nucleus to form trimeric export complexes, which then 307 
dissociate after export, accompanied by RanGTP hydrolysis aided by RanGAP (Fornerod et 308 
al., 1997a, Fung & Chook, 2014, Guttler & Gorlich, 2011, Koyama & Matsuura, 2012, 309 
Monecke et al., 2014). The role of Ran can be addressed by expressing mutant versions of 310 
Ran (encoded by the spi1+ gene in fission yeast; (Matsumoto & Beach, 1991)) that mimic 311 
either GTP or GDP states (Bischoff et al., 1994, Klebe et al., 1995). Constitutively-active 312 
Ran (RanQ69L in humans) is defective in GTP hydrolysis and thus “locked” in the RanGTP 313 
state, while inactive/dominant-negative Ran (RanT24N in humans) has low affinity for 314 
nucleotide and competes with endogenous RanGDP for binding to RanGEF.  315 
We expressed wild-type spi1+, spi1[Q68L] (equivalent to human RanQ69L), and 316 
spi1[T23N] (equivalent to human RanT24N) as integrated transgenes from a thiamine-317 
repressible promoter. All cells were viable under repressing conditions, but growth was 318 
impaired by expression of spi1[Q68L] or spi1[T23N] (Fig. 5—figure supplement 1), 319 
consistent with phenotypes of the equivalent mutants in vertebrate cells (Clarke et al., 1995, 320 
Dasso et al., 1994, Kornbluth et al., 1994, Ren et al., 1994). To avoid any indirect effects on 321 
Mto1[9A1-NE]-GFP localization as a result of growth impairment, we assayed localization as 322 
early as possible during expression (Fig. 5, Fig. 5—figure supplement 2). Expression of 323 
spi1+ had no effect on Mto1[9A1-NE]-GFP localization. Expression of spi1[Q68L] impaired 324 
import of a nuclear localization signal (NLS) reporter protein, as expected (Fig. 5—figure 325 
supplement 2), but did not alter Mto1[9A1-NE]-GFP localization to NPCs. Interestingly, 326 
expression of spi1[T23N], which had only minor effects on NLS reporter localization, led to 327 
strong loss of Mto1[9A1-NE]-GFP from NPCs (Fig. 5, Fig. 5—figure supplement 2). These 328 
results indicate that, like nuclear export, Mto1 localization to NPCs requires RanGTP. 329 
Moreover, at least in the short-term, neither RanGDP nor Ran nucleotide cycling is required 330 
for Mto1 NPC localization. 331 
 332 
Mto1-Crm1 complex docks at the NPC via Nup146 FG repeats. 333 
We next asked whether Nup146 contributes to Mto1 NPC localization. Like 334 
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approximately one-third of all nucleoporins, Nup146 and its homologs Sc Nup159 and Hs 335 
Nup214 contain multiple phenylalanine-glycine (FG) repeats, which bind directly to importins 336 
and/or exportins (Fig. 6—figure supplement 1A; (Aitchison & Rout, 2012, Wente & Rout, 337 
2010)). Because of their location on the cytoplasmic face of the NPC, these nucleoporins are 338 
classified as “cytoplasmic FG-Nups”, distinguishing them from the “symmetric FG-Nups” 339 
present within the central permeability barrier of the NPC. While FG repeats of symmetric 340 
FG-Nups directly facilitate cargo transport through the NPC, FG repeats of cytoplasmic FG-341 
Nups are thought not to be important for transport per se (Adams et al., 2014, Strawn et al., 342 
2004, Zeitler & Weis, 2004), although their other (non-FG) regions recruit proteins for 343 
processes linked to transport (e.g. mRNP processing after export (Napetschnig et al., 2007, 344 
Schmitt et al., 1999, Weirich et al., 2004); Fig. 6—figure supplement 1A). Nevertheless, the 345 
FG repeats of Sc Nup159 and Hs Nup214 have been shown to bind to Crm1 with high 346 
specificity relative to other importins/exportins. (Allen et al., 2002, Fornerod et al., 1997b, 347 
Hutten & Kehlenbach, 2006, Port et al., 2015, Roloff et al., 2013, Zeitler & Weis, 2004). We 348 
therefore focused attention on the Nup146 FG repeats. 349 
We deleted the 50-amino-acid region comprising FG repeats 5-12 (out of a total of 16 350 
FG repeats) from the endogenous nup146 coding sequence (Fig. 6A). Although complete 351 
deletion of nup146 is lethal (Chen et al., 2004), the nup146[∆FG5-12] strain was viable, and 352 
Nup146[∆FG5-12]-3mCherry was localized to NPCs. (Fig. 6—figure supplement 1B). 353 
Strikingly, in nup146[∆FG5-12] cells, Mto1[9A1-NE]-GFP no longer localized to NPCs and 354 
instead was present only in the cytoplasm (Fig. 6B; Fig. 6—figure supplement 1B). 355 
We also analyzed MTOC activity at the NE in wild-type (nup146+) cells vs. nup146 356 
[∆FG5-12] cells. First, we assayed MT regrowth after cold-induced depolymerization, in cells 357 
expressing full-length, untagged Mto1 (Fig. 6C). In wild-type cells, MT regrowth occurred 358 
from the NE, while in nup146[∆FG5-12] cells MT regrowth occurred randomly in the 359 
cytoplasm (Fig. 6C), similar to LMB-treated wild-type cells (Fig. 3—figure supplement 3). 360 
Second, we used live-cell imaging of GFP-tubulin to assay steady-state MT nucleation, in 361 
cells expressing Mto1[NE]-GFP (Fig. 6D, E; in these cells, Mto1[NE]-GFP is too faint to be 362 
seen relative to GFP-tubulin). In nup146[∆FG 5-12] cells, MT nucleation frequency in the 363 
vicinity of the NE was decreased by ~90% relative to wild-type (nup146+) cells, while 364 
nucleation frequency away from the NE was unchanged. 365 
Collectively, these results indicate that Nup146 FG repeats 5-12 are essential for Mto1 366 
docking at the NPC and, consequently, for MTOC nucleation from the NE. To our 367 
knowledge, this is the first biological function that can be uniquely attributed to the FG 368 
repeats of the Nup146/Sc Nup159/Hs Nup214 class of cytoplasmic FG-Nups, in any 369 
organism (see Discussion).  370 
 371 
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Nup146 FG repeats stabilize the Mto1-Crm1 interaction  372 
Our results thus far indicate that a RanGTP-dependent Mto1-Crm1 “cargo-like” complex 373 
docks at the cytoplasmic face of the NPC via a mechanism involving Nup146 FG repeats 374 
(see Fig. 7). Interestingly, a subset of FG repeats in Hs Nup214 have been shown to bind to 375 
Crm1 in a manner that stabilizes the Crm1-RanGTP-cargo interaction in vitro (Askjaer et al., 376 
1999, Fornerod et al., 1997b, Hutten & Kehlenbach, 2006, Kehlenbach et al., 1999, Port et 377 
al., 2015, Roloff et al., 2013). We therefore asked whether Nup146 FG repeats 5-12 are 378 
important for Mto1 interaction with Nup146, and whether these repeats contribute to Crm1 379 
association with Mto1 in vivo. We used LFQ MS to compare GFP-Mto1[9A1-NE]-HTB 380 
interactomes from wild-type (nup146+) vs. nup146[∆FG5-12] cells. Among more than 500 381 
quantified proteins, only 5-6 proteins were significantly enriched in the GFP-Mto1[9A1-NE]-382 
HTB interactome from nup146+ cells compared to nup146[∆FG5-12] cells. Nup146 itself 383 
showed the greatest enrichment (~11X), while Crm1 was also enriched, although to a lesser 384 
extent (~3X) (Fig. 6F; Table 4; Suppl. File 6). This suggests that Nup146 FG repeats are 385 
essential for interaction of Mto1 with Nup146. In addition, while Nup146 FG repeats may not 386 
be absolutely essential for formation of an Mto1-Crm1 complex, they may help to stabilize it.  387 
 388 
DISCUSSION 389 
While different mechanisms are involved in generating non-centrosomal MTOCs at 390 
different subcellular sites, at many sites the mechanisms themselves remain poorly 391 
understood (Petry & Vale, 2015, Sanchez & Feldman, 2017, Wu & Akhmanova, 2017). Here 392 
we have shown how MTOCs are generated at the NE in fission yeast S. pombe via the 393 
Mto1/2 complex. We find that Mto1 docks at the cytoplasmic face of NPCs, and this involves 394 
a novel mechanism in which the nuclear export machinery at NPCs is repurposed for a non-395 
export-related function. Docking depends on an export cargo-like interaction between a 396 
NES-like sequence (NES-M) at the Mto1 N-terminus and the NES-binding cleft of exportin 397 
Crm1, the major transport receptor for protein nuclear export (Fung & Chook, 2014, Hutten & 398 
Kehlenbach, 2007, Kutay & Guttinger, 2005). Docking further requires RanGTP and the 399 
central FG repeats of Nup146, a cytoplasmic FG-Nup homologous to Sc Nup159 and Hs 400 
Nup214. The general features of Mto1 docking at NPCs are summarized in Fig. 7. 401 
In this work, chemical cross-linking of cell cryogrindates allowed us to capture low-402 
affinity interactions that might otherwise be unstable during conventional purification. By 403 
using affinity tags compatible with strong denaturing conditions (Tagwerker et al., 2006), we 404 
were able to solubilize and interrogate protein-protein interactions that normally occur within 405 
“solid-phase” subcellular environments. In addition, by combining live-cell microscopy with 406 
LFQ MS (Cox & Mann, 2008) we were able to correlate changes in Mto1 localization with 407 
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changes in interactors on a near proteome-wide scale, and under several different 408 
comparative conditions. 409 
The mechanism described here for Mto1 localization to NPCs was entirely unexpected. 410 
While it incorporates many of the elements of conventional Crm1-dependent nuclear export 411 
(Fig. 7), there are two fundamental distinctions. First, when not interacting with the export 412 
machinery, Mto1(and its partner Mto2) is a cytoplasmic protein rather than a nuclear protein. 413 
Second, interaction of Mto1 with the export machinery leads to docking at NPCs, rather than 414 
a return/release into the cytoplasm. To our knowledge, this is the first example of a nuclear 415 
export-like complex being used to dock a cytoplasmic “cargo” at the NPC, with no obvious 416 
functional link to export. 417 
Nuclear transport receptors and nucleoporins are known to have non-transport-related 418 
roles away from NPCs, especially in relation to mitosis and microtubule function. In many 419 
cell types, importins play a major role in RanGTP-dependent regulation of mitotic spindle 420 
assembly factors, while Crm1 has been described to have roles both at centrosomes and 421 
kinetochores (reviewed in (Cavazza & Vernos, 2015, Forbes et al., 2015, Kalab & Heald, 422 
2008). In particular, in mammalian cells, Crm1 is involved in RanGTP-dependent 423 
kinetochore targeting of a complex containing RanGAP1 and RanBP2 (a metazoan-specific 424 
cytoplasmic FG-Nup, also known as Nup358,), and this is important for the integrity of 425 
kinetochore microtubules (Arnaoutov et al., 2005), perhaps because of the SUMO E3 ligase 426 
activity of RanBP2 (Ritterhoff et al., 2016). In this context, it is interesting to compare and 427 
contrast the role of Crm1 at the kinetochore with our proposed mechanism of Mto1 docking. 428 
While the role of Crm1 in Mto1 docking is to recruit a cargo-like molecule (i.e. Mto1) to 429 
NPCs, the role of Crm1 at the kinetochore is to recruit specific NPC components to a novel 430 
non-NPC site (likely via RanBP2’s FG repeats; (Ritterhoff et al., 2016)). In Crm1-dependent 431 
targeting of RanGAP1/RanBP2 to kinetochores, the Crm1 “cargo” remains unknown, and the 432 
mechanism by which Crm1 associates with kinetochores appears to be controversial 433 
(Platani et al., 2009, Zuccolo et al., 2007). We further note that recruitment of nucleoporins 434 
to the kinetochore is not restricted to the RanGAP1/RanBP2 complex. In many cell types, 435 
the multi-protein Nup107-160 complex (also known as Y complex; (Kabachinski & Schwartz, 436 
2015)) is also recruited to kinetochores, where it may promote MT nucleation by the -tubulin 437 
complex (Mishra et al., 2010). This process also depends on RanGTP, but any specific role 438 
for nuclear transport receptors here remains unclear. 439 
 440 
Docking at the NPC  441 
How does Mto1, a nuclear export cargo “mimic”, become docked at the NPC, while 442 
conventional export cargos are released into the cytoplasm? Ultimately, a detailed 443 
understanding of this issue will require in vitro biochemistry with purified proteins. However, 444 
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based on previous work in mammalian cells (Engelsma et al., 2004, Port et al., 2015), we 445 
speculate that docking may depend on: 1) the Mto1 NES-M acting as a high-affinity NES; 446 
and 2) the stability of interaction between Mto1-Crm1 and Nup146 FG repeats. 447 
The Mto1 NES-M is necessary and sufficient for docking at the NPC (Fig. 4). 448 
Interestingly, in human cells, cargo containing a non-natural, high-affinity NES (a 449 
“supraphysiological NES”) was shown to accumulate at the cytoplasmic face of the NPC and 450 
also to enhance Crm1 accumulation at the same site (Engelsma et al., 2004, Engelsma et 451 
al., 2008). We hypothesize that the Mto1 NES-M may be a natural high-affinity NES. In 452 
recent years, the NES “consensus” has evolved in concert with new experimental findings 453 
(Dong et al., 2009, Fung et al., 2015, Fung et al., 2017, Guttler et al., 2010, Monecke et al., 454 
2009). In particular, relative to an original consensus involving four spaced hydrophobic 455 
residues (Kutay & Guttinger, 2005), several high-affinity NESs depend on a fifth hydrophobic 456 
residue, which may also be present in the Mto1 NES-M (Fig. 4B). In this context, it is 457 
interesting that we found that Mto1[9A1-NE]-GFP localizes to NPCs in crm1-C529A mutants 458 
(Fig. 3B) but not in crm1-C529S, crm1-C529T, and crm1-C529V mutants, even though these 459 
mutants are viable and thus competent for nuclear export (Fig. 3—figure supplement 2). This 460 
may indicate that, relative to conventional NESs, the binding of the Mto1 NES-M to Crm1 461 
involves recognition of additional and/or distinct features within the Crm1 NES-binding cleft. 462 
Assuming that the Mto1 NES-M interacts with Crm1 as a high-affinity NES, clues as to 463 
how this could lead to accumulation at the NPC can be found in structural studies of Crm1 464 
alone and Crm1 in complex with RanGTP, cargo, and an FG-repeat fragment of Hs Nup214 465 
(Fig. 7—figure supplement 1A; (Dong et al., 2009, Guttler et al., 2010, Monecke et al., 2009, 466 
Monecke et al., 2013, Port et al., 2015, Saito & Matsuura, 2013)). Crm1 can exist in two 467 
conformations: an unliganded extended, superhelical conformation, which is inhibitory to 468 
cargo and RanGTP binding, and a compact, ring-like conformation, which is stabilized by 469 
cooperative binding to cargo and RanGTP. Importantly, the FG-repeat fragment of Hs 470 
Nup214, which binds Crm1 cooperatively with RanGTP and cargo, interacts with the 471 
compact conformation of Crm1 at multiple sites, spanning the junction between the Crm1 N- 472 
and C-termini in a manner similar to an adhesive bandage (Port et al., 2015) (Fig. 7—figure 473 
supplement 1A). The Hs Nup214 FG repeats have therefore been described as a “molecular 474 
clamp” that can stabilize Crm1-RanGTP-cargo complex in the compact conformation (Port et 475 
al., 2015). However, from an energetic perspective, cooperative binding also implies that 476 
anything that stabilizes the Crm1 compact conformation (including a high-affinity NES) will 477 
correspondingly reinforce association of Crm1 with Hs Nup214 FG repeats. As a result, a 478 
sufficiently high-affinity NES cargo would be expected to stabilize interaction of Crm1 with 479 
Nup146, leading to docking of Crm1 (and the NES cargo itself) at the cytoplasmic face of the 480 
NPC (Fig. 7—figure supplement 1A).  481 
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In addition to a “high-affinity NES” mechanism, other factors may also contribute to 482 
docking of the Mto1/2 complex at the NPC. For example, if Mto1(or its partner Mto2) were to 483 
bind Nup146 independently of binding to Crm1, such multivalent binding would decrease the 484 
off-rate from the NPC; currently our MS data cannot distinguish between direct and indirect 485 
Mto1 interactors. Interactions between Mto1/2 and the NPC could also be stabilized by 486 
avidity effects (Fig. 4E). Mto1/2 is multimeric in vivo, containing multiple (>10) copies of both 487 
Mto1 and Mto2 (Lynch et al., 2014), while nucleoporins are also present in multiple copies 488 
within the NPC, because of its eight-fold symmetry (Aitchison & Rout, 2012, Gorlich & Kutay, 489 
1999, Wente & Rout, 2010). As a result, multiple Mto1 molecules in a single Mto1/2 complex 490 
could bind to multiple nucleoporins (and/or Crm1) in a single NPC. Interestingly, localization 491 
of Mto1/2 to the SPB and the CAR also depends on avidity effects (Samejima et al., 2010).  492 
 493 
Formation of an Crm1-dependent docking complex with a cytoplasmic “cargo” 494 
Given that conventional Crm1-dependent export complexes form in the nucleus, where 495 
RanGTP concentration is high (Aitchison & Rout, 2012, Gorlich & Kutay, 1999, Wente & 496 
Rout, 2010), how might an Mto1/2 docking complex form in the cytoplasm, where RanGTP 497 
concentration is low? We speculate that if the Mto1 NES-M acts as a high-affinity NES, it 498 
may be possible for Mto1/2 to replace a conventional nuclear export cargo at the final stages 499 
of export, via a “cargo-handover” mechanism (Fig. 7—figure supplement 1B). Alternatively, a 500 
docking complex involving Mto1/2, Crm1, Nup146 and RanGTP could in principle form de 501 
novo at the cytoplasmic face of the NPC. While the low concentration of RanGTP in the 502 
cytoplasm makes this unlikely, it is formally possible that in the immediate vicinity of the 503 
NPC, the local concentration of RanGTP is higher than in the cytoplasm in general, because 504 
in yeast, RanGAP is freely soluble in the cytoplasm rather than associated with the NPC 505 
(Aitchison & Rout, 2012, Hopper et al., 1990). Accordingly, immediately after RanGTP 506 
dissociates from export complexes (but prior to GTP hydrolysis), it might be available to 507 
cytoplasmic Mto1/2. 508 
Our proposition that an Mto1/2 docking complex includes RanGTP (see Fig.7; Fig. 7—509 
figure supplement 1) is based on the observed requirement for RanGTP for docking in vivo 510 
and on analogy to the known mechanisms underlying stable NES-dependent binding of 511 
conventional nuclear export cargo to Crm1 (Dong et al., 2009, Guttler et al., 2010, Monecke 512 
et al., 2009, Monecke et al., 2013, Port et al., 2015, Saito & Matsuura, 2013). We note that 513 
in cross-linking MS experiments, we did not observe increased association of Ran with Mto1 514 
that is localized to the NE compared to Mto1 that is not localized to the NE (Suppl. Files 3-515 
6). One possible reason for this is that Ran may not be readily cross-linked to Mto1 or to 516 
Mto1’s immediate interactors (by analogy to conventional cargo export, Ran would not be 517 
expected to bind directly to Mto1). Alternatively, it is possible that the Mto1/2 docking 518 
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complex does not contain Ran and that the requirement for Ran-GTP for docking is only 519 
indirect. This might be the case if the main role of Ran-GTP in Mto1/2 docking is to generate 520 
sufficiently high levels of conventional export complexes at the cytoplasmic face NPC such 521 
that components of these complexes (e.g. Crm1) can subsequently be used for Mto1/2 522 
docking by an unconventional, Ran-independent mechanism. Further work with purified 523 
proteins may help to address this issue. 524 
 525 
A novel function for cytoplasmic FG-Nups? 526 
In this work, we identified a very specific phenotype associated with deletion of Nup146 527 
FG repeats 5-12: Mto1 is lost from NPCs, with a concomitant loss in MT nucleation from the 528 
NE. Moreover, this is correlated with a strong decrease in interaction of Mto1 with Nup146 529 
and, to a lesser extent, with Crm1, consistent with our model of a cargo-like complex of 530 
Mto1/2, Crm1 and RanGTP docking at the cytoplasmic face of the NPC. In this context, it is 531 
interesting that extensive analysis in budding yeast has shown that the FG regions of 532 
cytoplasmic FG-Nups (as well as nucleoplasmic FG-Nups) can be deleted without almost 533 
any discernible effects on nuclear transport (Adams et al., 2014, Strawn et al., 2004, Zeitler 534 
& Weis, 2004). In human cells, the role of Hs Nup214 in protein export appears to be 535 
somewhat controversial (Bernad et al., 2006, Hutten & Kehlenbach, 2006); however, similar 536 
to budding yeast, in at least one instance where Hs Nup214 was found to be important for 537 
export—namely, export of the 60S pre-ribosome— the FG repeats of Hs Nup214 were found 538 
not to be required (Bernad et al., 2006)). Based on these results, and on the conservation of 539 
FG repeats in Nup146, Sc Nup159 and Hs Nup214, we propose that an important but 540 
previously unrecognized role for cytoplasmic FG-Nups may be to dock cytoplasmic proteins 541 
at the NPC for non-export-related functions, as described here for generation of non-542 
centrosomal MTOCs by the Mto1/2 complex. It will be interesting to see how widespread this 543 
type of repurposing of the nuclear export machinery is in eukaryotic cells more generally. 544 
 545 
MATERIALS AND METHODS 546 
 547 
Key Resources 
Table 
 
   Reagent type 
(species) or 
resource 
Designation Source or 
reference Identifiers 
Additional 
information 
gene 
(Schizosaccharomyces 
pombe) 
Mto1 NA Pombase:SPCC417.07c   
gene (S. pombe) Mto2 NA Pombase:SPBC902.06   
gene (S. pombe) Crm1 NA Pombase:SPAC1805.17   
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gene (S. pombe) Nup146 NA Pombase:SPAC23D3.06c   
gene (S. pombe) Alp7 NA Pombase:SPAC890.02c   
gene (S. pombe) Nup132 NA Pombase:SPAC1805.04   
gene (S. pombe) Spi1 NA Pombase:SPBC1289.03c 
Spi1 is the S. 
pombe gene 
name for Ran 
GTPase 
gene (S. pombe) Plo1 NA Pombase:SPAC23C11.16   
gene (S. pombe) Alp14 NA Pombase:SPCC895.07   
gene (Saccharomyces 
cerevisiae) Nup159 NA SGD:S000001377 
Alternate 
systematic 
name YIL115C 
gene (Homo sapiens) Nup214 NA HGNC:8064 Alternate name CAN 
antibody 
TAT1 anti-
tubulin (mouse 
monoclonal) 
PMID:26069
40   
(1:15 of 
hybridoma 
supernatant) 
antibody 
Alexa Fluor 488 
secondary 
(donkey anti-
mouse 
polyclonal) 
Thermo 
Fisher 
Scientific 
Thermo Fisher 
Scientific:A-21202; 
RRID:AB_141607 
(1:80) 
antibody anti-GFP (rabbit polyclonal) Rockland 
Rockland:600-401-215; 
RRID:AB_828167 (1:400) 
antibody 
Alexa 594 
FluoroNanogold 
Fab’ fragment 
(goat anti-rabbit 
polyclonal) 
Nanoprobes Nanoprobes:7304 (1:400) 
antibody anti-GFP (sheep polyclonal) other   
homemade lab 
stock; used for 
immunoprecipita
tion 
commercial assay or kit 
QuikChange II 
Site Directed 
Mutagenesis Kit 
Agilent Agilent:200523   
chemical compound, 
drug Leptomycin B 
LC 
Laboratories LC Laboratories:L-6100   
software, algorithm Metamorph Molecular Devices RRID:SCR_002368   
software, algorithm Image J NIH RRID:SCR_003070   
software, algorithm Prism Graphpad RRID:SCR_002798   
software, algorithm Photoshop Adobe RRID:SCR_014199   
software, algorithm Illustrator Adobe RRID:SCR_010279   
software, algorithm MaxQuant PMID:19029910 RRID:SCR_014485   
software, algorithm MaxLFQ PMID:24942700     
software, algorithm Pombase PMID:25361970 RRID:SCR_006586   
other DAPI 
Thermo 
Fisher 
Scientific 
Thermo Fisher 
Scientific:D1306; 
RRID:AB_2629482 
  
other Protein G Dynabeads 
Thermo 
Fisher 
Scientific 
Thermo Fisher 
Scientific:10003D   
 18 
other Fractogel EMD Chelate (M) Merck KGaA Merck:1.10338.0010   
other 
Nanolink  
streptavidin 
magnetic beads 
Trilink Trilink:M-1002   
 548 
Yeast cultures, strain and plasmid construction 549 
Fission yeast methods and growth media were as described (Forsburg & Rhind, 2006, 550 
Petersen & Russell, 2016). Strains were normally grown in YE5S rich medium or PMG 551 
minimal medium (like EMM2, but using 5 g/L sodium glutamate acid instead of ammonium 552 
chloride as nitrogen source). For preliminary experiments using SILAC mass spectrometry, 553 
cells were grown in low-nitrogen EMM2 medium (“LowN”; using 0.3 g/L ammonium chloride 554 
as nitrogen source; (Bicho et al., 2010)). For purification of HTB-tagged Mto1 variants for 555 
LFQ MS, Mto1 variants were expressed from the nmt81 promoter, and cells were grown in 556 
PMG medium, except for experiments involving leptomycin B (Fig. 3), in which case Mto1 557 
variants were expressed from the repressed nmt1 promoter, and cells were grown in 558 
4xYE5S medium. For electron microscopy, cells were grown in EMM2 minimal medium. 559 
Nutritional supplements were normally used at 175 mg/L, except for arginine and lysine in 560 
SILAC experiments, in which unlabeled arginine or L-13C6-arginine (Sigma Isotec) was used 561 
at 80 mg/L, and unlabeled lysine or L-13C615N2-lysine (Sigma Isotec) was used at 60 mg/L 562 
(Bicho et al., 2010). Solid media contained 2% Bacto agar (Becton Dickinson). For mating, 563 
SPA plates containing 45 mg/L each of adenine, leucine, uracil, histidine and lysine were 564 
used. For repression of thiamine-regulated promoters, sterile-filtered thiamine was added to 565 
media at a final concentration of 15 µM.  566 
Strains used in this study are listed in Supplementary File 1. For experiments purifying 567 
HTB-tagged Mto1 for LFQ MS, strains contained the mto2[17A] allele; this allele contains 17 568 
phosphorylation sites in Mto2 mutated to alanine, which helps to stabilize the Mto1/2 569 
complex (Borek et al., 2015). The mto2[17A] allele was also present in strains imaged in 570 
Figs. 1C and 4C (see Supplementary File 1). 571 
Genetic crosses used either tetrad dissection or random spore analysis (Ekwall & Thon, 572 
2017). Except for the cases described below, genome manipulations such as gene tagging, 573 
truncation and/or deletion were made by homologous recombination of PCR products 574 
(Bahler et al., 1998, Hentges et al., 2005, Van Driessche et al., 2005). PCR was performed 575 
with either Phusion High-Fidelity polymerase or Q5 High-Fidelity polymerase (NEB). Desired 576 
strains were confirmed by yeast colony PCR, western blot and/or fluorescence microscopy 577 
as appropriate. For all cloning experiments, E. coli strain DH5alpha was used. 578 
 579 
Leptomycin-resistant crm1 mutants 580 
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To generate crm1-C529A/S/T/V mutants, a one-step approach was used, in which 581 
mto1[9A1-NE]-GFP nup146-3mCherry cells were transformed with mutated crm1 DNA 582 
fragments and selected directly for leptomycin (LMB) resistance. Mutant crm1 fragments 583 
were designed with the mutation site in the center, ~650 base pairs of crm1 sequence on 584 
either side of the mutation site, and BstXI sites at each end of fragment.  Plasmids 585 
containing the mutant fragments were synthesized by GeneArt (plasmids pKS1735, 586 
pKS1734, pKS1737, and pKS1738, for crm1-C529A, crm1-C529S, crm1-C529T, and crm1-587 
C529V mutants, respectively). The crm1 fragments were released from plasmids by BstXI 588 
digestion, purified and transformed into strain KS7255. Cells from the transformation were 589 
plated onto YE5S plates containing 300 nM LMB (LC Laboratories), and LMB-resistant 590 
colonies were easily identified. A negative-control transformation conducted in parallel did 591 
not yield any LMB-resistant colonies. Stable LMB-resistant colonies from each 592 
transformation were then used for sequencing to confirm specific mutations in crm1 genomic 593 
DNA. The mutant strains were named KS9340 (crm1-C529A), KS9221 (crm1-C529S) 594 
KS9338 (crm1-C529T), and KS9336 (crm1-C529V). 595 
 596 
Overexpression of wild-type and mutant spi1 597 
Strains overexpressing spi1+, spi1[Q68L] and spi1[T23N] from the nmt41 promoter were 598 
generated by targeted integration of transgenes at the hph.171k locus (Fennessy et al., 599 
2014). First, pJET-spi1+/[Q68L]/[T23N] plasmids were constructed. To construct pJET-600 
spi1+, spi1+ genomic DNA was amplified from fission yeast genomic DNA using primer pair 601 
OKS3290/OKS3291, and the PCR product was ligated into vector pJET1.2 (Thermo Fisher 602 
Scientific). The resulting pJET-spi1+ plasmid was confirmed by sequencing and named 603 
pKS1603. To construct pJET-spi1[Q68L], the Q68L mutation was introduced into pKS1603 604 
by PCR, using primer pair OKS3139/OKS3140. The PCR product was recircularized using 605 
T4 polynucleotide kinase and T4 DNA ligase. The resulting plasmid was confirmed by 606 
sequencing and named pKS1596. To construct pJET-spi1[T23N], pKS1603 was used as 607 
template to introduce the T23N mutation into the spi1 sequence, using QuikChange II Site-608 
Directed Mutagenesis kit (Agilent) and primer pair OKS 3336/OKS3337. After DpnI 609 
treatment and transformation, the resulting plasmid was confirmed by sequencing and 610 
named pKS1595. 611 
Next, the spi1 inserts from pKS1603, pKS1596, and pKS1595 were each subcloned into 612 
the fission yeast integration vector pINTH41 (Fennessy et al., 2014) after restriction digest 613 
with BamHI and NdeI. The resulting pINTH41-spi1+/[Q68L]/[T23N] plasmids were confirmed 614 
by restriction digest and named pKS1597, pKS1599, and pKS1598, respectively. 615 
For transformation into fission yeast, pKS1597, pKS1599, and pKS1598 were digested 616 
with NotI, and the relevant fragments were purified and used to transform strain KS 7742. 617 
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Stable nourseothricin-resistant, hygromycin-sensitive integrants were identified, indicating 618 
replacement of the hygromycin-resistance marker at the hph.171k locus by the transgene. 619 
Colonies were then tested on PMG plates (also containing adenine and uracil) with or 620 
without 15 µM thiamine. After two days of growth at 32°C, nmt41:spi1+ colonies were similar 621 
with and without thiamine, while nmt41:spi1[Q68L] and nmt41:spi1[T23N] colonies appeared 622 
normal on plates with thiamine but formed only very tiny colonies on plates without thiamine. 623 
nmt41: spi1+/[Q68L]/[T23N] overexpression strains were named KS8578, KS8581 and 624 
KS8580, respectively. 625 
 626 
Internal deletion of nup146 FG repeats 627 
Strains with internal deletions of nup146 FG repeats were constructed by a two-step 628 
approach (Fennessy et al., 2014). For the first step, an rpl42:natMX6 cassette was amplified 629 
by PCR using primer pair OKS2460/OKS2461 and the PCR product was used to transform 630 
cycloheximide-resistant rpl42.sP56Q strain KS8072. The amplified cassette was at the end 631 
of the nup146 coding sequence to generate a nourseothricin-resistant, cycloheximide-632 
sensitive nup146:rpl42:natMX6 rpl42.sP56Q strain, which was named KS8254.  633 
For the second step, a 5.1 kb wild-type nup146 genomic DNA fragment (containing 5’ 634 
and 3’ untranslated regions as well as coding sequence) was amplified by PCR using primer 635 
pair OKS3063/OKS3067. The PCR product was ligated into pJET1.2 vector, and the 636 
resulting pJET-nup146 plasmid was sequenced and named pKS1511. Internal deletions of 637 
FG repeats were made within pKS1511 by PCR, using primer pair OKS3093/OKS3094 to 638 
make nup146 [∆FG5-12∆]. The PCR product was recircularized using T4 polynucleotide 639 
kinase and T4 DNA ligase, and after transformation, the resulting plasmid was confirmed by 640 
sequencing. The pJET-nup146[∆FG5-12] genomic DNA plasmid was named pKS1514. 641 
DNA sequence of nup146 [∆FG5-12] was amplified from pKS1514 by PCR using primer 642 
pair OKS3098/OKS3099. The resulting PCR product was transformed into strain KS8254. 643 
Nourseothricin-sensitive, cycloheximide-resistant colonies were selected, and colony PCR 644 
using primer pair OKS3154/OKS3155 was used to identify the desired strains. The correct 645 
nup146[∆FG5-12] rpl42.sP56Q strains was named KS8305. 646 
 647 
Light microscopy 648 
General light microscopy conditions 649 
Unless stated otherwise, for live-cell microscopy, cells were grown in PMG medium 650 
supplemented with adenine, leucine and uracil, with glucose added after autoclaving. Before 651 
imaging, cells were grown for two days at 25°C, with appropriate dilution to maintain 652 
exponential growth. To prepare cells for imaging, 0.5-1 mL of cell culture was centrifuged at 653 
13,000 rpm for 30 s to pellet cells, and a small amount of cell pellet was placed on a pad of 654 
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2% agarose in PMG medium supplemented with adenine, leucine and uracil, on a 655 
microscope slide. The preparation was then sealed with a coverslip and VALAP (Vaseline, 656 
lanolin, and paraffin wax in a 1:1:1 ratio). Preparations were used for ~10-40 min before 657 
being discarded. 658 
All microscopy was performed on a spinning-disk confocal microscope, using a Nikon 659 
100x/1.45 NA Plan Apo objective and a Nikon TE2000 inverted microscope in a 25°C 660 
temperature-controlled box, attached to a Yokogawa CSU-10 spinning disk confocal unit 661 
(Visitech) and an Andor iXon+ Du888 EMCCD camera. 662 
Images were acquired with a step size 0.6 µm and 11 Z-sections for the full cell volume, 663 
except for imaging of GFP-tubulin, which used 7 Z-sections. Microscopy images were 664 
processed and analyzed by Metamorph (Molecular Devices) and Image J software. Figures 665 
were prepared using Photoshop and Illustrator (Adobe). Graphs and statistical analysis were 666 
prepared using Prism (Graphpad). Only linear contrast enhancement was used. Unless 667 
otherwise indicated, images are presented as maximum projection of all 11 Z-sections. 668 
Images within the same panel in a given figure were all acquired and processed under 669 
identical conditions, and therefore signal intensities can be compared directly. 670 
Unless stated otherwise, light-microscopy imaging experiments involved at least two 671 
independent biological replicates. We define a biological replicate as growing a fresh culture 672 
of a particular strain and taking it through to the end of the experiment. In a few cases, cells 673 
were imaged once during strain construction and then once more formally against the 674 
appropriate control strain (which itself may have been imaged multiple times). Imaging for 675 
Fig. 1 Suppl. 1B was done once, as this replicates previous work (Lynch et al., 2014) and is 676 
for illustration purposes only. 677 
 678 
Nuclear positioning 679 
For measuring nuclear position, 0.5 mL of exponentially-growing cells was centrifuged 680 
at 5000 RPM for 30 s, washed in deionized water, and resuspended in deionized water to a 681 
final volume of 10 µL. Cells were fixed by heat-denaturation on a coverslip on a 65°C hot 682 
block, and 2.5 µl of mounting media containing DAPI stain was added to fixed cells. 683 
Fluorescence images of stained nuclei were acquired together with bright-field images to 684 
show the entire cell. For analysis, fluorescence and bright-field images were overlaid using 685 
ImageJ, and the distance from the center of the nucleus to the nearest cell tip (S) and the 686 
furthest cell tip (L) was measured. We report eccentricity of nuclear position as the ratio S/L 687 
(i.e. for a perfectly-centered nucleus, S/L = 1). This experiment was done once, measuring 688 
S/L for 100 cells for each genotype. 689 
 690 
Leptomycin B (LMB) treatment 691 
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For imaging after LMB treatment, LMB (from 10 µM stock in ethanol) was added to 692 
cultures at 100 nM final concentration. For negative controls, ethanol alone was added to an 693 
equivalent final concentration (1% v/v). After incubation with or without LMB at 25°C, cells 694 
were mounted on medium-agarose pads containing 100 nM LMB and imaged as described 695 
above. In Fig. 3 Suppl. 1A (Alp7-3GFP +/- LMB), imaging was done once with 400 nM LMB 696 
and once with 100 nM LMB. In Fig. 4F (GFP-Mto1[1-29]-GST + LMB), imaging was done 697 
once. In Fig. 3—figure supplement 3 (MT regrowth), fixation, processing, and imaging was 698 
done once for each time-point, using 200 nM LMB. Because each different time-point was 699 
derived from a separate flask, similarities between neighboring time-points indicate 700 
reproducibility. 701 
 702 
Spi1 expression 703 
For imaging after expression of nmt41:spi1+, nmt41:spi1[Q68L], and nmt41:spi1[T23N], 704 
cells were first grown to exponential phase in PMG medium containing adenine, leucine and 705 
uracil, plus 15 µM thiamine to repress nmt41:spi1 expression. Cells of each strain, as well as 706 
control cells lacking any spi1 transgene, were centrifuged at 4000 rpm for 4 min, washed 707 
three times with deionized water, resuspended in medium without thiamine, and grown at 708 
25°C until imaging. Preliminary experiments indicated that at this temperature, expression 709 
was first noticeable ~26 h after washing, and more significant at 30-34 h after washing. Cells 710 
were therefore imaged after 26 h and 34 h incubation at 25°C. 711 
 712 
Microtubule re-growth after cold-shock 713 
For microtubule regrowth experiments, cells were grown in YE5S liquid medium at 714 
25°C. Manipulations before and after cold-shock, including methanol fixation and processing 715 
for immunofluorescence, were performed exactly as described previously (Lynch et al., 716 
2014). To assay regrowth after cold-shock, chilled cells were fixed at 34 s, 40 s, 55 s, 70 s, 3 717 
min, and 10 min after being returned to pre-warmed flasks in a 25°C water bath. Cells were 718 
stained with TAT1 mouse monoclonal anti-tubulin antibody (1:15 dilution of hybridoma 719 
culture supernatant; (Woods et al., 1989)) and Alexa488 Donkey anti-mouse secondary 720 
antibody (1:80 dilution; Thermo Fisher Scientific). Centrifugation of stained cells onto 721 
coverslips for imaging was as described (Sawin & Nurse, 1998). This experiment was 722 
performed once for each time-point. Because each different time-point was derived from a 723 
separate flask, similarities between neighboring time-points indicate reproducibility. 724 
 725 
GFP-tubulin live-cell imaging. 726 
For GFP-tubulin live-cell imaging of wild-type (nup146+) and nup146[∆FG5-12] cells, 727 
cells were imaged every 5 s for a total time of 100s. Each culture was grown once. 728 
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Quantification of MT nucleation in the vicinity of the cell nucleus and away from the cell 729 
nucleus was determined manually from videos. A total of 90 cells were scored for each of 730 
the two genotypes, and total nucleation events were pooled for each genotype. 731 
 732 
Immunoelectron microscopy 733 
Immunoelectron microscopy was carried out as described previously (Tange et al., 734 
2016), with some modifications. Briefly, strain KS5750 (mto1[9A1-NE]-GFP) was cultured in 735 
EMM2 medium with supplements. After washing with 0.1 M phosphate buffer (PB, pH7.4), 736 
cells were fixed for 20 min at room temperature with 4% formaldehyde and 0.01% 737 
glutaraldehyde dissolved in PB, and washed with PB three times for 5 min each.  Cells were 738 
then treated with 0.5 mg/mL Zymolyase 100T (Seikagaku Co., Tokyo, Japan) in PB for 30 739 
min. Because the cell walls were not removed well, the cells were further treated with 1 740 
mg/mL Zymolyase 100T in PB for 30 min at 30°C, with 0.2 mg/ml Lysing Enzyme for 30 min, 741 
and washed with PB three times. After treatment with 100 mM lysine HCl in PB twice for 10 742 
min and subsequent washing with PB, cells were permeabilized for 15 min with PB 743 
containing 0.2% saponin and 1% bovine serum albumin (BSA), and incubated at 4°C 744 
overnight with primary antibody (rabbit polyclonal anti-GFP antibody; Rockland) diluted 745 
1:400 in PB containing 1% BSA and 0.01% saponin. After washing with PB containing 746 
0.005% saponin three times for 10 min each, cells were incubated for 2 hours at room 747 
temperature with secondary antibody (goat anti-rabbit Alexa 594 FluoroNanogold Fab’ 748 
fragment, Nanoprobes, Yaphank, NY, USA) diluted 1:400 in PB containing 1% BSA and 749 
0.01% saponin, washed with PB containing 0.005% saponin three times for 10 min each, 750 
and with PB once. Then, the cells were fixed again with 1% glutaraldehyde in PB for 1 hour, 751 
washed with PB once and treated with 100 mM lysine HCl in PB twice for 10 min each. The 752 
cells were stored at 4°C until further use. 753 
Before use, the cells were incubated with 50 mM HEPES (pH5.8) three times for 3 min 754 
each, washed with distilled water (dH2O) once, and then incubated at 25°C for 3 min with 755 
the Silver enhancement reagent (an equal-volume mixture of the following solutions A, B 756 
and C: A. 0.2% silver acetate solution. B. 2.8% trisodium citrate-2H2O, 3% citric acid-H2O, 757 
and 0.5% hydroquinone. C. 300 mM HEPES, pH 8.2). Cells were then washed with dH2O 758 
three times. Cells were embedded in 2% low melting agarose dissolved in dH2O. Then, cells 759 
were post-fixed with 2% OsO4 in dH2O for 15 min at room temperature, washed with dH2O 760 
three times, stained with 1% uranyl acetate in DW for 1 hour, and washed with dH2O three 761 
times. 762 
Cells were dehydrated by sequential incubation in 50 and 100% ethanol for 10 min 763 
each, and with acetone for 10 min. For embedding in epoxy resin, cells were incubated 764 
sequentially with mixtures of acetone: Epon812 (1:1) for 1hr, acetone:Epon812 (1:2) for 1hr, 765 
 24 
and Epon812 overnight, and then Epon812 again for another 3 hours, and left to stand until 766 
solidified. The block containing cells was sectioned with a microtome (Leica Microsystems), 767 
and the ultra-thin sections were doubly stained with 4% uranyl acetate for 20 min and lead 768 
citrate (Sigma, Tokyo Japan) for 1 min as usually treated in EM methods. Images were 769 
obtained using a JEM1400 transmission electron microscope (JEOL, Tokyo, Japan) at 770 
120kV. Images shown are taken from one of three independent biological replicate 771 
experiments. 772 
 773 
Biochemistry and mass spectrometry 774 
Cell harvesting and cryogrinding 775 
Cell cultures in late exponential growth were collected by centrifugation at 5000 rpm for 776 
15 mins at 4°C in a JLA-8.1000 rotor (Beckman Coulter). Cell pellets were resuspended in 777 
one-quarter culture volume of wash buffer (10mM NaPO4 pH 7.5 and 0.5 mM EDTA) and 778 
then washed three times by centrifugation at 5000 rpm for 15 mins at 4°C in a JLA-10.500 779 
rotor (Beckman Coulter) and resuspension in the same volume of wash buffer. After the final 780 
centrifugation, the cell pellet was weighed and resuspended in wash buffer, using a ratio of 781 
0.3 mL wash buffer per gram of cell pellet. The cell suspension was then quick-frozen by 782 
drop-wise addition into liquid nitrogen and stored at -80°C until further use. 783 
Cryogrinding was performed using an RM100 electric mortar grinder with a zirconium 784 
oxide mortar and pestle (Retsch). The mortar and pestle were pre-cooled by filling with liquid 785 
nitrogen for 10 min before grinding. Frozen cells were then added into the pre-cooled grinder 786 
and ground for 40 min, with regular generous addition of liquid nitrogen to maintain the 787 
temperature and prevent cell clumping during the grinding process. Cryogrindate cell powder 788 
was recovered and stored at -80°C until further use. 789 
 790 
Anti-GFP immunoprecipitation (for preliminary SILAC interactome analysis) 791 
Large-scale anti-GFP immunoprecipitation was performed using homemade sheep anti-792 
GFP antibody covalently coupled to Protein G Dynabeads (Thermo Fisher Scientific) using 793 
dimethylpimelimidate (Borek et al., 2015). Immunoprecipitation (IP) buffer contained 15 mM 794 
NaPO4 pH 7.5, 100 mM KCl, 0.5 mM EDTA, 0.2% TX-100, 10 µg/mL CLAAPE protease 795 
inhibitors (chymostatin, leupeptin, antipain dihydrochloride, aprotinin, pepstatin, E-64), 2 mM 796 
AEBSF, 2 mM PMSF, 1 mM NaF, 50 nM calyculin A, 50 nM okadaic acid, 0.1 mM Na3VO4, 797 
and 2 mM benzamidine.  798 
After SILAC labeling, cell harvesting and cryogrinding, 37 g of cell cryogrindate powder 799 
was mixed with 66.6 ml of cold (4°C) IP buffer and vortexed until dissolved. Cell lysate was 800 
then centrifuged at 13,000 rpm for 15 min at 4°C to remove most of the cell debris. The 801 
supernatant was transferred to a fresh tube and centrifuged again at 13,000 rpm for 15 min 802 
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at 4°C, and the second supernatant was recovered. Protein concentration of clarified lysates 803 
was measured by Bradford assay and then normalized by adding appropriate volume of IP 804 
buffer as necessary.  805 
For immunoprecipitation, 140 µL of anti-GFP/Protein G-Dynabead slurry (~2.1x109 806 
beads, coupled to ~85 µg of antibody) were washed twice with 0.5 mL of IP buffer, mixed 807 
with 70 mL of clarified cell lysate, and incubated at 4°C for 1.5 h with gentle rotation. Beads 808 
were then collected with a magnet, washed three times with 1 mL IP buffer, transferred to a 809 
fresh microfuge tube, and washed twice again with 1 mL IP buffer. The beads were then 810 
centrifuged at 13,000 rpm for 10 s, and any remaining buffer was removed. 811 
To elute proteins from beads, a total of 65 µL Laemmli sample buffer (LSB; 2% SDS 812 
(v/v), 10% glycerol, 62.5 mM Tris pH 6.8) was added to beads, which were then mixed by 813 
pipetting and incubated at 65°C for 15 min with intermittent vortexing. The mixture was then 814 
briefly centrifuged before transferring the supernatant to a fresh microfuge tube, and DTT 815 
and bromophenol blue were added to final concentrations of 0.1 M and 0.01%, respectively. 816 
This final sample was then heated at 95°C for 5 min and stored at -20°C prior to SDS-PAGE. 817 
Samples from large-scale immunoprecipitations were processed for SILAC mass 818 
spectrometry analysis as described below. 819 
 820 
Cryogrindate cross-linking in vitro 821 
A 0.125 M stock solution of disuccinimidyl suberate (DSS; Thermo Fisher Scientific) was 822 
made fresh in DMSO. Just before cross-linking, this was diluted to 2.5 mM final 823 
concentration in cross-linking buffer (15 mM NaPO4 pH 7.5, 85 mM NaCl, 0.2% Triton X-824 
100, 1 mM PMSF, 10 µg/mL CLAAPE protease inhibitors, 2 mM AEBSF, 1 mM NaF, 50 nM 825 
okadaic acid, 0.1 mM Na3VO4 and 2 mM benzamidine). 6 g of cell cryogrindate powder was 826 
resuspended in 6 mL of cross-linking buffer containing DSS and mixed by vortexing. Cell 827 
lysate was then incubated at 4°C for 2 h with gentle rotation. Then, 1.2 mL of 1.5 M Tris-HCl 828 
pH 8.8 was added to the cell lysate to quench the cross-linking reaction, and left at room 829 
temperature for 30 min. The cross-linked cell lysate was then used for two-step purification 830 
as described below. 831 
 832 
Two-step purification of HTB-tagged Mto1 variants 833 
HTB-tagged Mto1 variants were purified in two steps, using nickel-charged Fractogel 834 
EMD Chelate (M) (Merck) resin and Nanolink magnetic streptavidin beads (Solulink), under 835 
denaturing conditions. The procedure described below was used for purifications after 836 
cryogrindate cross-linking in vitro, which was most commonly used. For purifications after 837 
cross-linking in vivo, the same approach was used, but all amounts and volumes were 838 
 26 
doubled (this is because initial purifications were done after cross-linking in vivo, and it was 839 
later determined that half as much material was still sufficient for MS analysis) 840 
For the first-step purification, 12 mL of cross-linked and quenched cell lysate 841 
(representing 6 g cryogrindate) was mixed with 60 mL guanidine purification buffer (6 M 842 
guanidine, 15 mM NaPO4 pH 7.5, 85 mM NaCl, 0.5% TritonX-100, 1 mM PMSF, 1 mM NaF, 843 
0.1 mM Na3VO4 and 2 mM benzamidine). The cell lysate was then sonicated with a Sonics 844 
VC505 sonicator fitted with a 3mm tip for 2 min (1 s on, 1 s off, for total time 4 min, at 60% 845 
amplification), centrifuged at 4,000 rpm for 15 min at room temperature to remove cell 846 
debris, and the supernatant was recovered. 1.2 mL of 50% slurry of Fractogel EMD Chelate 847 
(henceforth referred to as “Fractogel”) was charged with nickel and washed twice with 5 mL 848 
distilled water, and twice with 5 mL guanidine purification buffer. The charged Fractogel bed 849 
was resuspended with an equal volume of 6 M guanidine purification buffer and mixed with 850 
the lysate supernatant and incubated at room temperature for 2 h, with gentle rotation. The 851 
suspension was then transferred to a 20 mL disposable plastic column (Evergreen 852 
Scientific), washed once with 20 mL of 6 M guanidine purification buffer, and washed 3 times 853 
with 20 mL of 8M urea purification buffer (contained 8 M urea, 15 mM NaPO4 pH 7.5, 85 mM 854 
NaCl, 0.1% TritonX-100, 1 mM PMSF, 1 mM NaF, 0.1 mM Na3VO4 and 2 mM benzamidine). 855 
The Fractogel was then resuspended in 1 mL of 8 M urea purification buffer and transferred 856 
into a 15 mL polypropylene tube. This process was repeated for 2 more times to recover all 857 
of the Fractogel from the column. Fractogel was then centrifuged at 4,000 rpm for 3 min at 858 
RT. The supernatant was discarded, and 3 mL of LSB containing 600 mM imidazole was 859 
added to the tube, and bound proteins were eluted by heating at 95°C for 5 min. The 860 
Fractogel was then centrifuged at 4,000 rpm for 3 min, and the supernatant was recovered, 861 
quick-frozen in liquid nitrogen, and stored at -80°C. 862 
For the second-step purification, the stored elution from the first-step purification above 863 
was thawed at room temperature, and TX-100 was added to a final concentration of 1%. 30 864 
µL of Nanolink streptavidin beads slurry (as supplied by manufacturer; this corresponds to 865 
~1.2 µL bed volume) was washed twice with 1 mL of LSB containing 1% TX-100, 866 
resuspended into 30 µL of LSB containing 1% TX-100 and added to the thawed first-step 867 
elution. This suspension was incubated for 1.5 h at room temperature, then collected with a 868 
magnet and washed once with 1 mL of LSB and three times with 1 mL of LSB without 869 
glycerol. After transfer to a microfuge tube, beads were resuspended in 15 µL of LSB and 870 
heated at 95°C for 5 min. The elution from the beads was collected and DTT and 871 
bromophenol blue were added, to final concentrations of 0.1M and 0.01%, respectively. The 872 
mixture was boiled again for 5 min and stored at -20°C prior to SDS-PAGE. 873 
 874 
Mass spectrometry (label-free quantification) 875 
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For label-free quantification mass spectrometry analysis of samples after two-step 876 
purification, ~18 µL of second-step elution was loaded onto a single lane (~0.5 cm wide) of a 877 
4-20% Tris-glycine polyacrylamide gel (Biorad). Samples were run at 150V for 12-14 min. 878 
The gel was stained with Coomassie Blue at room temperature for 1 h and destained in 10% 879 
acetic acid overnight. On the following day, the gel was washed once in distilled water and 880 
the relevant region recovered after excision with a clean scalpel. In general, for all samples, 881 
we recovered the region of the gel above, but not including, the non-cross-linked Mto1 band, 882 
in order to increase the relative proportion of cross-linked Mto1 species vs. non-crosslinked 883 
Mto1.  884 
Excised gel bands were destained with 50mM ammonium bicarbonate (Sigma Aldrich, 885 
UK) and 100% (v/v) acetonitrile (Sigma Aldrich, UK) and proteins were digested with trypsin, 886 
as previously described (Shevchenko et al., 1996). In brief, proteins were reduced in 10 mM 887 
dithiothreitol (Sigma Aldrich, UK) for 30 min at 37°C and alkylated in 55 mM iodoacetamide 888 
(Sigma Aldrich, UK) for 20 min at ambient temperature in the dark. They were then digested 889 
overnight at 37°C with 13 ng/μL trypsin (Pierce, UK).  890 
Following digestion, samples were diluted with an equal volume of 0.1% TFA and spun 891 
onto StageTips as described (Rappsilber et al., 2003). Peptides were eluted in 40 μL of 80% 892 
acetonitrile in 0.1% TFA and concentrated to 1 μL by vacuum centrifugation (Concentrator 893 
5301, Eppendorf, UK). Samples were then prepared for LC-MS/MS analysis by diluting to 5 894 
μL with 0.1% TFA. LC-MS-analyses were performed on a Q Exactive mass spectrometer 895 
(Thermo Fisher Scientific, UK) (Figures 1, 3, and 6) and on an Orbitrap Fusion™ Lumos™ 896 
Tribrid™ Mass Spectrometer (Thermo Fisher Scientific, UK) (Figure 4), both coupled on-line 897 
to Ultimate 3000 RSLCnano Systems (Dionex, Thermo Fisher Scientific, UK). Peptides were 898 
separated on a 50 cm EASY-Spray column (Thermo Scientific, UK) assembled in an EASY-899 
Spray source (Thermo Scientific, UK) and operated at 50oC. In both cases, mobile phase A 900 
consisted of 0.1% formic acid in water while mobile phase B consisted of 80% acetonitrile 901 
and 0.1% formic acid. Peptides were loaded onto the column at a flow rate of 0.3 μL/min and 902 
eluted at a flow rate of 0.2 μL/min according to the following gradients: 2 to 40% buffer B in 903 
90 min, then to 95% buffer B in 11 min (Figures 1, 3 and 4) and 2 to 40% buffer B in 120 min 904 
and then to 95% buffer B in 11 min (Figure 6). For Q Exactive, FTMS spectra were recorded 905 
at 70,000 resolution (scan range 350-1400 m/z) and the ten most intense peaks with charge 906 
≥ 2 of the MS scan were selected with an isolation window of 2.0 Thomson for MS2 (filling 907 
1.0E6 ions for MS scan, 5.0E4 ions for MS2, maximum fill time 60 ms, dynamic exclusion for 908 
50 s). For Orbitrap Fusion Lumos, survey scans were performed at 60,000 resolution (scan 909 
range 350-1400 m/z) with an ion target of 7.0e5. MS2 was performed in the orbitrap with ion 910 
target of 5.0E3 and HCD fragmentation with normalized collision energy of 25 (Olsen et al., 911 
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2007). The isolation window in the quadrupole was 1.6. Only ions with charge between 2 912 
and 7 were selected for MS2.   913 
The MaxQuant software platform (Cox & Mann, 2008) version 1.5.2.8 was used to 914 
process raw files, and search was conducted against Schizosaccharomyces pombe 915 
complete/reference proteome set from PomBase (www.pombase.org; released in July, 916 
2016; McDowall et al., 2015), using the Andromeda search engine (Cox et al., 2011). The 917 
first search peptide tolerance was set to 20 ppm while the main search peptide tolerance 918 
was set to 4.5 ppm. Isotope mass tolerance was set to 2 ppm, and maximum charge state 919 
was set to 7. Maximum of two missed cleavages were allowed. Carbamidomethylation of 920 
cysteine was set as fixed modification. Oxidation of methionine and acetylation of the N-921 
terminal were set as variable modifications. Label-free quantification analysis was performed 922 
by employing the MaxLFQ algorithm as described (Cox et al., 2014). Peptide and protein 923 
identifications were filtered to 1% FDR. 924 
All LFQ MS was performed using two complete biological replicates of each of the two 925 
conditions being compared. For experiments shown in Fig. 6, additional biological replicates 926 
using cells grown in LowN medium were also performed, alongside those using cells grown 927 
in PMG (as normal). Including the LowN replicates during MaxQuant analysis improved the 928 
quality of peptide identifications from experiments using cells grown in PMG. Data shown in 929 
Fig. 6 are only from cells grown in PMG; however, data from cells grown in LowN are 930 
completely consistent with the data from cells grown in PMG and are included with the PMG 931 
data as part of Supplementary File 6. 932 
Scatterplots showing LFQ ratio vs. LFQ intensity (Figs. 1, 3, 4, 6) were constructed as 933 
follows: In cases where the relevant Mto1-interactors (e.g. Crm1, Nup146) were fully 934 
quantified in both conditions of both replicate experiments (i.e. Figs. 3 & 6), the values 935 
shown in scatterplots represent the geometric mean from the two replicates. The geometric 936 
mean was used rather than the arithmetic mean in order to minimize any effects of extreme 937 
outliers. In other cases (i.e. Figs. 1 & 4), Nup146 was not fully quantified in one of the 938 
conditions of one of the replicate experiments, because of low signal intensity or low peptide 939 
count. In these cases, it was not possible to calculate mean LFQ values for Nup146 from 940 
replicate experiments, and therefore, the values shown in scatterplots are taken from the 941 
replicate in which the Nup146 was fully quantified. Tables 1-4 show peptide counts and LFQ 942 
values for selected proteins from replicate experiments, and Supplementary Files 3-6 943 
contain full datasets, including LFQ values. 944 
 945 
Mass spectrometry (SILAC) 946 
To generate the SILAC data shown in Supplementary File 2 (preliminary results, from 947 
anti-GFP immunoprecipitation), sample processing and digestion was performed as 948 
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described above. LC-MS analyses were performed on a Q Exactive mass spectrometer 949 
(Thermo Fisher Scientific, UK) coupled on-line, to Ultimate 3000 RSLCnano Systems 950 
(Dionex, Thermo Fisher Scientific, UK). The analytical column with a self-assembled particle 951 
frit (Ishihama et al., 2002) and C18 material (ReproSil-Pur C18-AQ 3 μm; Dr. Maisch, 952 
GmbH, Germany) was packed into a spray emitter (75-μm ID, 8-μm opening, 300-mm 953 
length; New Objective) using an air-pressure pump (Proxeon Biosystems, USA). Mobile 954 
phase A consisted of 0.1% formic acid in water while mobile phase B consisted of 80% 955 
acetonitrile and 0.1% formic acid. Peptides were loaded onto the column at a flow rate of 0.5 956 
μL/min and eluted at a flow rate of 0.2 μL/min according to the following gradient: 2 to 40% in 957 
120 min and then to 95% in 11 min. The settings on the Q Exactive were the same as 958 
described above.  959 
The MaxQuant software platform (Cox & Mann, 2008) version 1.3.0.5 was used to 960 
process raw files, and search was conducted against Schizosaccharomyces pombe 961 
complete/reference proteome set from PomBase (released in August, 2012), using the 962 
Andromeda search engine (Cox et al., 2011). The first search peptide tolerance was set to 963 
20 ppm, while the main search peptide tolerance was set to 4.5 ppm. Isotope mass 964 
tolerance was 2 ppm and maximum charge was set to 7. The MS/MS match tolerance was 965 
set to 20 ppm, and two missed cleavages were allowed. Carbamidomethylation of cysteine 966 
was set as fixed modification, and oxidation of methionine with acetylation of the N-terminal 967 
were set as variable modifications. Multiplicity was set to 2, and for heavy labels, Arginine-6 968 
and Lysine-8 were selected, and peptide and protein identifications were filtered to 1% FDR. 969 
Unique and non-unique peptides were used for quantification. Proteins with minimum of two 970 
quantified labeled peptide pairs/triplets were reported for quantification, and the isoforms 971 
with the highest peptide counts were considered for quantification. 972 
The mass spectrometry proteomics data from both LFQ and SILAC experiments have 973 
been deposited to the ProteomeXchange Consortium via the PRIDE (Vizcaino et al., 2016) 974 
partner repository with the dataset identifier PXD008334. 975 
 976 
  977 
ACKNOWLEDGEMENTS 978 
We thank I. Hagan, S. Oliferenko, M. Sato, and K. Weis for yeast strains, plasmids 979 
and/or reagents. We thank members of our labs for helpful discussions, and A. Cook for 980 
insights on nuclear transport and for comments on the manuscript. This work was supported 981 
by the Wellcome Trust ([094517] to KES, and [108504], [091020] to JR), and by KAKENHI 982 
grants from the Japan Society for the Promotion of Science (JP25116006 and JP17H03636 983 
to TH, and JP17H01444 and JP16H01309 to YH). XXB was also supported by the Darwin 984 
 30 
Trust of Edinburgh. The Wellcome Centre for Cell Biology is supported by core funding from 985 
the Wellcome Trust [203149]. 986 
 987 
REFERENCES 988 
Adachi Y, Yanagida M (1989) Higher order chromosome structure is affected by cold-989 
sensitive mutations in a Schizosaccharomyces pombe gene crm1+ which encodes a 115-990 
kD protein preferentially localized in the nucleus and its periphery. J Cell Biol 108: 1195-991 
207. 992 
Adams RL, Terry LJ, Wente SR (2014) Nucleoporin FG domains facilitate mRNP remodeling 993 
at the cytoplasmic face of the nuclear pore complex. Genetics 197: 1213-24. 994 
Aitchison JD, Rout MP (2012) The yeast nuclear pore complex and transport through it. 995 
Genetics 190: 855-83. 996 
Allen NP, Patel SS, Huang L, Chalkley RJ, Burlingame A, Lutzmann M, Hurt EC, Rexach M 997 
(2002) Deciphering networks of protein interactions at the nuclear pore complex. Mol Cell 998 
Proteomics 1: 930-46. 999 
Ambrose C, Wasteneys GO (2014) Microtubule initiation from the nuclear surface controls 1000 
cortical microtubule growth polarity and orientation in Arabidopsis thaliana. Plant Cell 1001 
Physiol 55: 1636-45. 1002 
Arnaoutov A, Azuma Y, Ribbeck K, Joseph J, Boyarchuk Y, Karpova T, McNally J, Dasso M 1003 
(2005) Crm1 is a mitotic effector of Ran-GTP in somatic cells. Nat Cell Biol 7: 626-32. 1004 
Asakawa H, Yang HJ, Yamamoto TG, Ohtsuki C, Chikashige Y, Sakata-Sogawa K, 1005 
Tokunaga M, Iwamoto M, Hiraoka Y, Haraguchi T (2014) Characterization of nuclear pore 1006 
complex components in fission yeast Schizosaccharomyces pombe. Nucleus 5: 149-62. 1007 
Askjaer P, Bachi A, Wilm M, Bischoff FR, Weeks DL, Ogniewski V, Ohno M, Niehrs C, 1008 
Kjems J, Mattaj IW, Fornerod M (1999) RanGTP-regulated interactions of CRM1 with 1009 
nucleoporins and a shuttling DEAD-box helicase. Mol Cell Biol 19: 6276-85. 1010 
Bahler J, Wu JQ, Longtine MS, Shah NG, McKenzie A, 3rd, Steever AB, Wach A, Philippsen 1011 
P, Pringle JR (1998) Heterologous modules for efficient and versatile PCR-based gene 1012 
targeting in Schizosaccharomyces pombe. Yeast 14: 943-51. 1013 
Bai SW, Rouquette J, Umeda M, Faigle W, Loew D, Sazer S, Doye V (2004) The fission 1014 
yeast Nup107-120 complex functionally interacts with the small GTPase Ran/Spi1 and is 1015 
required for mRNA export, nuclear pore distribution, and proper cell division. Mol Cell Biol 1016 
24: 6379-92. 1017 
Bartolini F, Gundersen GG (2006) Generation of noncentrosomal microtubule arrays. J Cell 1018 
Sci 119: 4155-63. 1019 
Belgareh N, Snay-Hodge C, Pasteau F, Dagher S, Cole CN, Doye V (1998) Functional 1020 
characterization of a Nup159p-containing nuclear pore subcomplex. Mol Biol Cell 9: 3475-1021 
92. 1022 
Bernad R, Engelsma D, Sanderson H, Pickersgill H, Fornerod M (2006) Nup214-Nup88 1023 
nucleoporin subcomplex is required for CRM1-mediated 60 S preribosomal nuclear export. 1024 
J Biol Chem 281: 19378-86. 1025 
Bicho CC, de Lima Alves F, Chen ZA, Rappsilber J, Sawin KE (2010) A genetic engineering 1026 
solution to the "arginine conversion problem" in stable isotope labeling by amino acids in 1027 
cell culture (SILAC). Mol Cell Proteomics 9: 1567-77. 1028 
Bischoff FR, Klebe C, Kretschmer J, Wittinghofer A, Ponstingl H (1994) RanGAP1 induces 1029 
GTPase activity of nuclear Ras-related Ran. Proc Natl Acad Sci U S A 91: 2587-91. 1030 
Borek WE, Groocock LM, Samejima I, Zou J, de Lima Alves F, Rappsilber J, Sawin KE 1031 
(2015) Mto2 multisite phosphorylation inactivates non-spindle microtubule nucleation 1032 
complexes during mitosis. Nat Commun 6: 7929. 1033 
Bugnard E, Zaal KJ, Ralston E (2005) Reorganization of microtubule nucleation during 1034 
muscle differentiation. Cell Motil Cytoskeleton 60: 1-13. 1035 
Cavazza T, Vernos I (2015) The RanGTP Pathway: From Nucleo-Cytoplasmic Transport to 1036 
Spindle Assembly and Beyond. Front Cell Dev Biol 3: 82. 1037 
 31 
Chang F, Martin SG (2009) Shaping fission yeast with microtubules. Cold Spring Harb 1038 
Perspect Biol 1: a001347. 1039 
Chen XQ, Du X, Liu J, Balasubramanian MK, Balasundaram D (2004) Identification of genes 1040 
encoding putative nucleoporins and transport factors in the fission yeast 1041 
Schizosaccharomyces pombe: a deletion analysis. Yeast 21: 495-509. 1042 
Choi YK, Liu P, Sze SK, Dai C, Qi RZ (2010) CDK5RAP2 stimulates microtubule nucleation 1043 
by the gamma-tubulin ring complex. J Cell Biol 191: 1089-95. 1044 
Clarke PR, Klebe C, Wittinghofer A, Karsenti E (1995) Regulation of Cdc2/cyclin B activation 1045 
by Ran, a Ras-related GTPase. J Cell Sci 108 ( Pt 3): 1217-25. 1046 
Cox J, Hein MY, Luber CA, Paron I, Nagaraj N, Mann M (2014) Accurate proteome-wide 1047 
label-free quantification by delayed normalization and maximal peptide ratio extraction, 1048 
termed MaxLFQ. Mol Cell Proteomics 13: 2513-26. 1049 
Cox J, Mann M (2008) MaxQuant enables high peptide identification rates, individualized 1050 
p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 26: 1051 
1367-72. 1052 
Cox J, Neuhauser N, Michalski A, Scheltema RA, Olsen JV, Mann M (2011) Andromeda: a 1053 
peptide search engine integrated into the MaxQuant environment. J Proteome Res 10: 1054 
1794-805. 1055 
Daga RR, Chang F (2005) Dynamic positioning of the fission yeast cell division plane. Proc 1056 
Natl Acad Sci U S A 102: 8228-32. 1057 
Dasso M, Seki T, Azuma Y, Ohba T, Nishimoto T (1994) A mutant form of the Ran/TC4 1058 
protein disrupts nuclear function in Xenopus laevis egg extracts by inhibiting the RCC1 1059 
protein, a regulator of chromosome condensation. Embo J 13: 5732-44. 1060 
Dong X, Biswas A, Suel KE, Jackson LK, Martinez R, Gu H, Chook YM (2009) Structural 1061 
basis for leucine-rich nuclear export signal recognition by CRM1. Nature 458: 1136-41. 1062 
Drozdetskiy A, Cole C, Procter J, Barton GJ (2015) JPred4: a protein secondary structure 1063 
prediction server. Nucleic Acids Res 43: W389-94. 1064 
Ekwall K, Thon G (2017) Genetic Analysis of Schizosaccharomyces pombe. Cold Spring 1065 
Harb Protoc 2017: pdb top079772. 1066 
Engelsma D, Bernad R, Calafat J, Fornerod M (2004) Supraphysiological nuclear export 1067 
signals bind CRM1 independently of RanGTP and arrest at Nup358. Embo J 23: 3643-52. 1068 
Engelsma D, Valle N, Fish A, Salome N, Almendral JM, Fornerod M (2008) A 1069 
supraphysiological nuclear export signal is required for parvovirus nuclear export. Mol Biol 1070 
Cell 19: 2544-52. 1071 
Erhardt M, Stoppin-Mellet V, Campagne S, Canaday J, Mutterer J, Fabian T, Sauter M, 1072 
Muller T, Peter C, Lambert AM, Schmit AC (2002) The plant Spc98p homologue 1073 
colocalizes with gamma-tubulin at microtubule nucleation sites and is required for 1074 
microtubule nucleation. J Cell Sci 115: 2423-31. 1075 
Fant X, Srsen V, Espigat-Georger A, Merdes A (2009) Nuclei of non-muscle cells bind 1076 
centrosome proteins upon fusion with differentiating myoblasts. PLoS One 4: e8303. 1077 
Fennessy D, Grallert A, Krapp A, Cokoja A, Bridge AJ, Petersen J, Patel A, Tallada VA, 1078 
Boke E, Hodgson B, Simanis V, Hagan IM (2014) Extending the Schizosaccharomyces 1079 
pombe molecular genetic toolbox. PLoS One 9: e97683. 1080 
Fernandez-Martinez J, Kim SJ, Shi Y, Upla P, Pellarin R, Gagnon M, Chemmama IE, Wang 1081 
J, Nudelman I, Zhang W, Williams R, Rice WJ, Stokes DL, Zenklusen D, Chait BT, Sali A, 1082 
Rout MP (2016) Structure and Function of the Nuclear Pore Complex Cytoplasmic mRNA 1083 
Export Platform. Cell 167: 1215-1228 e25. 1084 
Forbes DJ, Travesa A, Nord MS, Bernis C (2015) Nuclear transport factors: global regulation 1085 
of mitosis. Curr Opin Cell Biol 35: 78-90. 1086 
Fornerod M, Ohno M, Yoshida M, Mattaj IW (1997a) CRM1 is an export receptor for leucine-1087 
rich nuclear export signals. Cell 90: 1051-60. 1088 
Fornerod M, van Deursen J, van Baal S, Reynolds A, Davis D, Murti KG, Fransen J, 1089 
Grosveld G (1997b) The human homologue of yeast CRM1 is in a dynamic subcomplex 1090 
with CAN/Nup214 and a novel nuclear pore component Nup88. Embo J 16: 807-16. 1091 
Forsburg SL, Rhind N (2006) Basic methods for fission yeast. Yeast 23: 173-83. 1092 
 32 
Fukuda M, Asano S, Nakamura T, Adachi M, Yoshida M, Yanagida M, Nishida E (1997) 1093 
CRM1 is responsible for intracellular transport mediated by the nuclear export signal. 1094 
Nature 390: 308-11. 1095 
Fung HY, Chook YM (2014) Atomic basis of CRM1-cargo recognition, release and inhibition. 1096 
Semin Cancer Biol 27: 52-61. 1097 
Fung HY, Fu SC, Brautigam CA, Chook YM (2015) Structural determinants of nuclear export 1098 
signal orientation in binding to exportin CRM1. Elife 4 1099 
Fung HY, Fu SC, Chook YM (2017) Nuclear export receptor CRM1 recognizes diverse 1100 
conformations in nuclear export signals. Elife 6 1101 
Gorlich D, Kutay U (1999) Transport between the cell nucleus and the cytoplasm. Annu Rev 1102 
Cell Dev Biol 15: 607-60. 1103 
Gorsch LC, Dockendorff TC, Cole CN (1995) A conditional allele of the novel repeat-1104 
containing yeast nucleoporin RAT7/NUP159 causes both rapid cessation of mRNA export 1105 
and reversible clustering of nuclear pore complexes. J Cell Biol 129: 939-55. 1106 
Goshima G, Mayer M, Zhang N, Stuurman N, Vale RD (2008) Augmin: a protein complex 1107 
required for centrosome-independent microtubule generation within the spindle. J Cell Biol 1108 
181: 421-9. 1109 
Guttler T, Gorlich D (2011) Ran-dependent nuclear export mediators: a structural 1110 
perspective. Embo J 30: 3457-74. 1111 
Guttler T, Madl T, Neumann P, Deichsel D, Corsini L, Monecke T, Ficner R, Sattler M, 1112 
Gorlich D (2010) NES consensus redefined by structures of PKI-type and Rev-type nuclear 1113 
export signals bound to CRM1. Nat Struct Mol Biol 17: 1367-76. 1114 
Hentges P, Van Driessche B, Tafforeau L, Vandenhaute J, Carr AM (2005) Three novel 1115 
antibiotic marker cassettes for gene disruption and marker switching in 1116 
Schizosaccharomyces pombe. Yeast 22: 1013-9. 1117 
Hopper AK, Traglia HM, Dunst RW (1990) The yeast RNA1 gene product necessary for 1118 
RNA processing is located in the cytosol and apparently excluded from the nucleus. J Cell 1119 
Biol 111: 309-21. 1120 
Hutten S, Kehlenbach RH (2006) Nup214 is required for CRM1-dependent nuclear protein 1121 
export in vivo. Mol Cell Biol 26: 6772-85. 1122 
Hutten S, Kehlenbach RH (2007) CRM1-mediated nuclear export: to the pore and beyond. 1123 
Trends Cell Biol 17: 193-201. 1124 
Ishihama Y, Rappsilber J, Andersen JS, Mann M (2002) Microcolumns with self-assembled 1125 
particle frits for proteomics. J Chromatogr A 979: 233-9. 1126 
Janski N, Masoud K, Batzenschlager M, Herzog E, Evrard JL, Houlne G, Bourge M, 1127 
Chaboute ME, Schmit AC (2012) The GCP3-interacting proteins GIP1 and GIP2 are 1128 
required for gamma-tubulin complex protein localization, spindle integrity, and 1129 
chromosomal stability. Plant Cell 24: 1171-87. 1130 
Janson ME, Setty TG, Paoletti A, Tran PT (2005) Efficient formation of bipolar microtubule 1131 
bundles requires microtubule-bound gamma-tubulin complexes. J Cell Biol 169: 297-308. 1132 
Kabachinski G, Schwartz TU (2015) The nuclear pore complex--structure and function at a 1133 
glance. J Cell Sci 128: 423-9. 1134 
Kalab P, Heald R (2008) The RanGTP gradient - a GPS for the mitotic spindle. J Cell Sci 1135 
121: 1577-86. 1136 
Kapitein LC, Hoogenraad CC (2015) Building the Neuronal Microtubule Cytoskeleton. 1137 
Neuron 87: 492-506. 1138 
Kehlenbach RH, Dickmanns A, Kehlenbach A, Guan T, Gerace L (1999) A role for RanBP1 1139 
in the release of CRM1 from the nuclear pore complex in a terminal step of nuclear export. 1140 
J Cell Biol 145: 645-57. 1141 
Klebe C, Bischoff FR, Ponstingl H, Wittinghofer A (1995) Interaction of the nuclear GTP-1142 
binding protein Ran with its regulatory proteins RCC1 and RanGAP1. Biochemistry 34: 1143 
639-47. 1144 
Kollman JM, Merdes A, Mourey L, Agard DA (2011) Microtubule nucleation by gamma-1145 
tubulin complexes. Nat Rev Mol Cell Biol 12: 709-21. 1146 
 33 
Kornbluth S, Dasso M, Newport J (1994) Evidence for a dual role for TC4 protein in 1147 
regulating nuclear structure and cell cycle progression. J Cell Biol 125: 705-19. 1148 
Koyama M, Matsuura Y (2010) An allosteric mechanism to displace nuclear export cargo 1149 
from CRM1 and RanGTP by RanBP1. Embo J 29: 2002-13. 1150 
Koyama M, Matsuura Y (2012) Mechanistic insights from the recent structures of the CRM1 1151 
nuclear export complex and its disassembly intermediate. Biophysics (Nagoya-shi) 8: 145-1152 
50. 1153 
Kraemer D, Wozniak RW, Blobel G, Radu A (1994) The human CAN protein, a putative 1154 
oncogene product associated with myeloid leukemogenesis, is a nuclear pore complex 1155 
protein that faces the cytoplasm. Proc Natl Acad Sci U S A 91: 1519-23. 1156 
Kraemer DM, Strambio-de-Castillia C, Blobel G, Rout MP (1995) The essential yeast 1157 
nucleoporin NUP159 is located on the cytoplasmic side of the nuclear pore complex and 1158 
serves in karyopherin-mediated binding of transport substrate. J Biol Chem 270: 19017-21. 1159 
Kudo N, Matsumori N, Taoka H, Fujiwara D, Schreiner EP, Wolff B, Yoshida M, Horinouchi 1160 
S (1999) Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine 1161 
residue in the central conserved region. Proc Natl Acad Sci U S A 96: 9112-7. 1162 
Kutay U, Guttinger S (2005) Leucine-rich nuclear-export signals: born to be weak. Trends 1163 
Cell Biol 15: 121-4. 1164 
Lin TC, Neuner A, Schiebel E (2015) Targeting of gamma-tubulin complexes to microtubule 1165 
organizing centers: conservation and divergence. Trends Cell Biol 25: 296-307. 1166 
Ling YC, Vjestica A, Oliferenko S (2009) Nucleocytoplasmic shuttling of the TACC protein 1167 
Mia1p/Alp7p is required for remodeling of microtubule arrays during the cell cycle. PLoS 1168 
One 4: e6255. 1169 
Liu T, Tian J, Wang G, Yu Y, Wang C, Ma Y, Zhang X, Xia G, Liu B, Kong Z (2014) Augmin 1170 
triggers microtubule-dependent microtubule nucleation in interphase plant cells. Curr Biol 1171 
24: 2708-13. 1172 
Lo Presti L, Chang F, Martin SG (2012) Myosin Vs organize actin cables in fission yeast. Mol 1173 
Biol Cell 23: 4579-91. 1174 
Lynch EM, Groocock LM, Borek WE, Sawin KE (2014) Activation of the gamma-tubulin 1175 
complex by the Mto1/2 complex. Curr Biol 24: 896-903. 1176 
Masoud K, Herzog E, Chaboute ME, Schmit AC (2013) Microtubule nucleation and 1177 
establishment of the mitotic spindle in vascular plant cells. Plant J 75: 245-57. 1178 
Matsumoto T, Beach D (1991) Premature initiation of mitosis in yeast lacking RCC1 or an 1179 
interacting GTPase. Cell 66: 347-60. 1180 
Matsuyama A, Arai R, Yashiroda Y, Shirai A, Kamata A, Sekido S, Kobayashi Y, Hashimoto 1181 
A, Hamamoto M, Hiraoka Y, Horinouchi S, Yoshida M (2006) ORFeome cloning and global 1182 
analysis of protein localization in the fission yeast Schizosaccharomyces pombe. Nat 1183 
Biotechnol 24: 841-7. 1184 
McDowall MD, Harris MA, Lock A, Rutherford K, Staines DM, Bahler J, Kersey PJ, Oliver 1185 
SG, Wood V (2015) PomBase 2015: updates to the fission yeast database. Nucleic Acids 1186 
Res 43: D656-61. 1187 
Mishra RK, Chakraborty P, Arnaoutov A, Fontoura BM, Dasso M (2010) The Nup107-160 1188 
complex and gamma-TuRC regulate microtubule polymerization at kinetochores. Nat Cell 1189 
Biol 12: 164-9. 1190 
Mogessie B, Roth D, Rahil Z, Straube A (2015) A novel isoform of MAP4 organises the 1191 
paraxial microtubule array required for muscle cell differentiation. Elife 4: e05697. 1192 
Monecke T, Dickmanns A, Ficner R (2014) Allosteric control of the exportin CRM1 unraveled 1193 
by crystal structure analysis. FEBS J 281: 4179-94. 1194 
Monecke T, Guttler T, Neumann P, Dickmanns A, Gorlich D, Ficner R (2009) Crystal 1195 
structure of the nuclear export receptor CRM1 in complex with Snurportin1 and RanGTP. 1196 
Science 324: 1087-91. 1197 
Monecke T, Haselbach D, Voss B, Russek A, Neumann P, Thomson E, Hurt E, Zachariae U, 1198 
Stark H, Grubmuller H, Dickmanns A, Ficner R (2013) Structural basis for cooperativity of 1199 
CRM1 export complex formation. Proc Natl Acad Sci U S A 110: 960-5. 1200 
 34 
Nakamura M, Yagi N, Kato T, Fujita S, Kawashima N, Ehrhardt DW, Hashimoto T (2012) 1201 
Arabidopsis GCP3-interacting protein 1/MOZART 1 is an integral component of the 1202 
gamma-tubulin-containing microtubule nucleating complex. Plant J 71: 216-25. 1203 
Napetschnig J, Blobel G, Hoelz A (2007) Crystal structure of the N-terminal domain of the 1204 
human protooncogene Nup214/CAN. Proc Natl Acad Sci U S A 104: 1783-8. 1205 
Oda Y (2015) Cortical microtubule rearrangements and cell wall patterning. Front Plant Sci 1206 
6: 236. 1207 
Ohkura H, Hagan IM, Glover DM (1995) The conserved Schizosaccharomyces pombe 1208 
kinase plo1, required to form a bipolar spindle, the actin ring, and septum, can drive 1209 
septum formation in G1 and G2 cells. Genes Dev 9: 1059-73. 1210 
Okada N, Sato M (2015) Spatiotemporal Regulation of Nuclear Transport Machinery and 1211 
Microtubule Organization. Cells 4: 406-26. 1212 
Okada N, Toda T, Yamamoto M, Sato M (2014) CDK-dependent phosphorylation of Alp7-1213 
Alp14 (TACC-TOG) promotes its nuclear accumulation and spindle microtubule assembly. 1214 
Mol Biol Cell 25: 1969-82. 1215 
Olsen JV, Macek B, Lange O, Makarov A, Horning S, Mann M (2007) Higher-energy C-trap 1216 
dissociation for peptide modification analysis. Nat Methods 4: 709-12. 1217 
Ong SE, Blagoev B, Kratchmarova I, Kristensen DB, Steen H, Pandey A, Mann M (2002) 1218 
Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate 1219 
approach to expression proteomics. Mol Cell Proteomics 1: 376-86. 1220 
Ossareh-Nazari B, Bachelerie F, Dargemont C (1997) Evidence for a role of CRM1 in signal-1221 
mediated nuclear protein export. Science 278: 141-4. 1222 
Petersen J, Russell P (2016) Growth and the Environment of Schizosaccharomyces pombe. 1223 
Cold Spring Harb Protoc 2016: pdb top079764. 1224 
Petry S, Vale RD (2015) Microtubule nucleation at the centrosome and beyond. Nat Cell Biol 1225 
17: 1089-93. 1226 
Platani M, Santarella-Mellwig R, Posch M, Walczak R, Swedlow JR, Mattaj IW (2009) The 1227 
Nup107-160 nucleoporin complex promotes mitotic events via control of the localization 1228 
state of the chromosome passenger complex. Mol Biol Cell 20: 5260-75. 1229 
Port SA, Monecke T, Dickmanns A, Spillner C, Hofele R, Urlaub H, Ficner R, Kehlenbach 1230 
RH (2015) Structural and Functional Characterization of CRM1-Nup214 Interactions 1231 
Reveals Multiple FG-Binding Sites Involved in Nuclear Export. Cell Rep 13: 690-702. 1232 
Rappsilber J, Ishihama Y, Mann M (2003) Stop and go extraction tips for matrix-assisted 1233 
laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in 1234 
proteomics. Anal Chem 75: 663-70. 1235 
Ren M, Coutavas E, D'Eustachio P, Rush MG (1994) Effects of mutant Ran/TC4 proteins on 1236 
cell cycle progression. Mol Cell Biol 14: 4216-24. 1237 
Ritterhoff T, Das H, Hofhaus G, Schroder RR, Flotho A, Melchior F (2016) The 1238 
RanBP2/RanGAP1*SUMO1/Ubc9 SUMO E3 ligase is a disassembly machine for Crm1-1239 
dependent nuclear export complexes. Nat Commun 7: 11482. 1240 
Rivero S, Cardenas J, Bornens M, Rios RM (2009) Microtubule nucleation at the cis-side of 1241 
the Golgi apparatus requires AKAP450 and GM130. Embo J 28: 1016-28. 1242 
Roloff S, Spillner C, Kehlenbach RH (2013) Several phenylalanine-glycine motives in the 1243 
nucleoporin Nup214 are essential for binding of the nuclear export receptor CRM1. J Biol 1244 
Chem 288: 3952-63. 1245 
Saito N, Matsuura Y (2013) A 2.1-A-resolution crystal structure of unliganded CRM1 reveals 1246 
the mechanism of autoinhibition. J Mol Biol 425: 350-64. 1247 
Samejima I, Lourenco PC, Snaith HA, Sawin KE (2005) Fission yeast mto2p regulates 1248 
microtubule nucleation by the centrosomin-related protein mto1p. Mol Biol Cell 16: 3040-1249 
51. 1250 
Samejima I, Miller VJ, Groocock LM, Sawin KE (2008) Two distinct regions of Mto1 are 1251 
required for normal microtubule nucleation and efficient association with the gamma-tubulin 1252 
complex in vivo. J Cell Sci 121: 3971-80. 1253 
Samejima I, Miller VJ, Rincon SA, Sawin KE (2010) Fission yeast Mto1 regulates diversity of 1254 
cytoplasmic microtubule organizing centers. Curr Biol 20: 1959-65. 1255 
 35 
Sanchez AD, Feldman JL (2017) Microtubule-organizing centers: from the centrosome to 1256 
non-centrosomal sites. Curr Opin Cell Biol 44: 93-101. 1257 
Sanchez-Huertas C, Freixo F, Viais R, Lacasa C, Soriano E, Luders J (2016) Non-1258 
centrosomal nucleation mediated by augmin organizes microtubules in post-mitotic 1259 
neurons and controls axonal microtubule polarity. Nat Commun 7: 12187. 1260 
Sato M, Okada N, Kakui Y, Yamamoto M, Yoshida M, Toda T (2009) Nucleocytoplasmic 1261 
transport of Alp7/TACC organizes spatiotemporal microtubule formation in fission yeast. 1262 
EMBO Rep 10: 1161-7. 1263 
Sato M, Vardy L, Angel Garcia M, Koonrugsa N, Toda T (2004) Interdependency of fission 1264 
yeast Alp14/TOG and coiled coil protein Alp7 in microtubule localization and bipolar spindle 1265 
formation. Mol Biol Cell 15: 1609-22. 1266 
Sawin KE, Lourenco PC, Snaith HA (2004) Microtubule nucleation at non-spindle pole body 1267 
microtubule-organizing centers requires fission yeast centrosomin-related protein mod20p. 1268 
Curr Biol 14: 763-75. 1269 
Sawin KE, Nurse P (1998) Regulation of cell polarity by microtubules in fission yeast. J Cell 1270 
Biol 142: 457-71. 1271 
Sawin KE, Tran PT (2006) Cytoplasmic microtubule organization in fission yeast. Yeast 23: 1272 
1001-1014. 1273 
Schmitt C, von Kobbe C, Bachi A, Pante N, Rodrigues JP, Boscheron C, Rigaut G, Wilm M, 1274 
Seraphin B, Carmo-Fonseca M, Izaurralde E (1999) Dbp5, a DEAD-box protein required 1275 
for mRNA export, is recruited to the cytoplasmic fibrils of nuclear pore complex via a 1276 
conserved interaction with CAN/Nup159p. Embo J 18: 4332-47. 1277 
Seltzer V, Janski N, Canaday J, Herzog E, Erhardt M, Evrard JL, Schmit AC (2007) 1278 
Arabidopsis GCP2 and GCP3 are part of a soluble gamma-tubulin complex and have 1279 
nuclear envelope targeting domains. Plant J 52: 322-31. 1280 
Shevchenko A, Wilm M, Vorm O, Mann M (1996) Mass spectrometric sequencing of proteins 1281 
silver-stained polyacrylamide gels. Anal Chem 68: 850-8. 1282 
Srsen V, Fant X, Heald R, Rabouille C, Merdes A (2009) Centrosome proteins form an 1283 
insoluble perinuclear matrix during muscle cell differentiation. BMC Cell Biol 10: 28. 1284 
Stade K, Ford CS, Guthrie C, Weis K (1997) Exportin 1 (Crm1p) is an essential nuclear 1285 
export factor. Cell 90: 1041-50. 1286 
Stoppin V, Vantard M, Schmit AC, Lambert AM (1994) Isolated Plant Nuclei Nucleate 1287 
Microtubule Assembly: The Nuclear Surface in Higher Plants Has Centrosome-like Activity. 1288 
Plant Cell 6: 1099-1106. 1289 
Strawn LA, Shen T, Shulga N, Goldfarb DS, Wente SR (2004) Minimal nuclear pore 1290 
complexes define FG repeat domains essential for transport. Nat Cell Biol 6: 197-206. 1291 
Tagwerker C, Flick K, Cui M, Guerrero C, Dou Y, Auer B, Baldi P, Huang L, Kaiser P (2006) 1292 
A tandem affinity tag for two-step purification under fully denaturing conditions: application 1293 
in ubiquitin profiling and protein complex identification combined with in vivo cross-linking. 1294 
Mol Cell Proteomics 5: 737-48. 1295 
Tange Y, Chikashige Y, Takahata S, Kawakami K, Higashi M, Mori C, Kojidani T, Hirano Y, 1296 
Asakawa H, Murakami Y, Haraguchi T, Hiraoka Y (2016) Inner nuclear membrane protein 1297 
Lem2 augments heterochromatin formation in response to nutritional conditions. Genes 1298 
Cells 21: 812-32. 1299 
Tassin AM, Maro B, Bornens M (1985) Fate of microtubule-organizing centers during 1300 
myogenesis in vitro. J Cell Biol 100: 35-46. 1301 
Tran PT, Marsh L, Doye V, Inoue S, Chang F (2001) A mechanism for nuclear positioning in 1302 
fission yeast based on microtubule pushing. J Cell Biol 153: 397-411. 1303 
Tyanova S, Temu T, Cox J (2016) The MaxQuant computational platform for mass 1304 
spectrometry-based shotgun proteomics. Nat Protoc 11: 2301-2319. 1305 
Van Driessche B, Tafforeau L, Hentges P, Carr AM, Vandenhaute J (2005) Additional 1306 
vectors for PCR-based gene tagging in Saccharomyces cerevisiae and 1307 
Schizosaccharomyces pombe using nourseothricin resistance. Yeast 22: 1061-8. 1308 
 36 
Venkatram S, Jennings JL, Link A, Gould KL (2005) Mto2p, a novel fission yeast protein 1309 
required for cytoplasmic microtubule organization and anchoring of the cytokinetic actin 1310 
ring. Mol Biol Cell 16: 3052-63. 1311 
Venkatram S, Tasto JJ, Feoktistova A, Jennings JL, Link AJ, Gould KL (2004) Identification 1312 
and characterization of two novel proteins affecting fission yeast gamma-tubulin complex 1313 
function. Mol Biol Cell 15: 2287-301. 1314 
Vizcaino JA, Csordas A, del-Toro N, Dianes JA, Griss J, Lavidas I, Mayer G, Perez-Riverol 1315 
Y, Reisinger F, Ternent T, Xu QW, Wang R, Hermjakob H (2016) 2016 update of the 1316 
PRIDE database and its related tools. Nucleic Acids Res 44: D447-56. 1317 
Weirich CS, Erzberger JP, Berger JM, Weis K (2004) The N-terminal domain of Nup159 1318 
forms a beta-propeller that functions in mRNA export by tethering the helicase Dbp5 to the 1319 
nuclear pore. Mol Cell 16: 749-60. 1320 
Wente SR, Rout MP (2010) The nuclear pore complex and nuclear transport. Cold Spring 1321 
Harb Perspect Biol 2: a000562. 1322 
Woods A, Sherwin T, Sasse R, MacRae TH, Baines AJ, Gull K (1989) Definition of individual 1323 
components within the cytoskeleton of Trypanosoma brucei by a library of monoclonal 1324 
antibodies. J Cell Sci 93: 491-500. 1325 
Wu J, Akhmanova A (2017) Microtubule-Organizing Centers. Annu Rev Cell Dev Biol  1326 
Wu J, de Heus C, Liu Q, Bouchet BP, Noordstra I, Jiang K, Hua S, Martin M, Yang C, 1327 
Grigoriev I, Katrukha EA, Altelaar AF, Hoogenraad CC, Qi RZ, Klumperman J, Akhmanova 1328 
A (2016) Molecular Pathway of Microtubule Organization at the Golgi Apparatus. Dev Cell 1329 
39: 44-60. 1330 
Xu D, Marquis K, Pei J, Fu SC, Cagatay T, Grishin NV, Chook YM (2015) LocNES: a 1331 
computational tool for locating classical NESs in CRM1 cargo proteins. Bioinformatics 31: 1332 
1357-65. 1333 
Yoshida K, Seo HS, Debler EW, Blobel G, Hoelz A (2011) Structural and functional analysis 1334 
of an essential nucleoporin heterotrimer on the cytoplasmic face of the nuclear pore 1335 
complex. Proc Natl Acad Sci U S A 108: 16571-6. 1336 
Zebrowski DC, Vergarajauregui S, Wu CC, Piatkowski T, Becker R, Leone M, Hirth S, 1337 
Ricciardi F, Falk N, Giessl A, Just S, Braun T, Weidinger G, Engel FB (2015) 1338 
Developmental alterations in centrosome integrity contribute to the post-mitotic state of 1339 
mammalian cardiomyocytes. Elife 4 1340 
Zeitler B, Weis K (2004) The FG-repeat asymmetry of the nuclear pore complex is 1341 
dispensable for bulk nucleocytoplasmic transport in vivo. J Cell Biol 167: 583-90. 1342 
Zhang J, Megraw TL (2007) Proper recruitment of gamma-tubulin and D-TACC/Msps to 1343 
embryonic Drosophila centrosomes requires Centrosomin Motif 1. Mol Biol Cell 18: 4037-1344 
49. 1345 
Zheng L, Schwartz C, Wee L, Oliferenko S (2006) The fission yeast transforming acidic 1346 
coiled coil-related protein Mia1p/Alp7p is required for formation and maintenance of 1347 
persistent microtubule-organizing centers at the nuclear envelope. Mol Biol Cell 17: 2212-1348 
22. 1349 
Zuccolo M, Alves A, Galy V, Bolhy S, Formstecher E, Racine V, Sibarita JB, Fukagawa T, 1350 
Shiekhattar R, Yen T, Doye V (2007) The human Nup107-160 nuclear pore subcomplex 1351 
contributes to proper kinetochore functions. Embo J 26: 1853-64. 1352 
  1353 
 37 
TABLES 1354 
 1355 
Table 1 1356 
Data for selected proteins from mass spectrometry comparison of GFP-Mto1[9A1-NE]-1357 
HTB and GFP-Mto1[9A1-bonsai]-HTB interactomes. 1358 
Peptide counts and label-free quantification (LFQ) values for selected proteins shown in Fig. 1359 
1F. Data from two independent biological replicates are shown. Nsp1 and Nup82 are 1360 
included as likely representative Nup146 interactors, based on homology to budding yeast 1361 
(Belgareh et al., 1998, PMID 9843582). See also Supplementary File 3. 1362 
 1363 
Protein 
Replicate 1 (E160307) Replicate 2 (E161126) 
Peptides 
from 
strain 
KS7611 
Peptides 
from 
strain 
KS8371 
LFQ 
intensity 
from 
strain 
KS7611 
LFQ 
intensity 
from 
strain 
KS8371 
LFQ 
Ratio  
Peptides 
from 
strain 
KS7611 
Peptides 
from 
strain 
KS8371 
LFQ 
intensity 
from 
strain 
KS7611 
LFQ 
intensity 
from 
strain 
KS8371 
LFQ 
Ratio  
Alp7 17 3 2.3e8 7.5e6 30.5 14 5 1.9e8 3.7e7 5.2 
Crm1 20 5 2.7e8 1.7e7 15.6 18 5 2.7e8 2.0e7 13.7 
Mto1 59 46 2.8e11 2.3e11 1.2 52 43 2.8e11 2.5e11 1.1 
Mto2 14 20 6.6e9 5.1e9 1.3 16 22 6.7e9 5.8e9 1.2 
Nsp1 14 11 2.5e8 1.8e8 1.4 14 12 2.2e8 1.3e8 1.7 
Nup146 20 2 2.1e8 7.7e6 27.3 20 1 2.1e8 NQ NQ 
Nup82 13 9 1.5e8 7.3e7 2.1 9 4 7.4e7 2.2e7 3.4 
Plo1 28 13 4.9e8 1.1e8 4.6 20 9 3.3e8 6.3e7 5.3 
 1364 
NQ = not quantified, because peptide count in the relevant sample was below threshold for 1365 
quantification. 1366 
 1367 
 1368 
  1369 
Table 2 1370 
Data for selected proteins from mass spectrometry comparison of GFP-Mto1[9A1-NE]-1371 
HTB interactomes from control cells and after treatment with leptomycin B. 1372 
Peptide counts and label-free quantification (LFQ) values for selected proteins from the two 1373 
replicate experiments contributing to the graph in Fig. 3C. See also Supplementary File 4. 1374 
 1375 
Protein 
Replicate 1 (E150924) Replicate 2 (E151106) 
Peptides 
from 
strain 
KS7669 
-LMB 
Peptides 
from 
strain 
KS7669 
+LMB 
LFQ 
intensity 
from 
strain 
KS7669 
-LMB 
LFQ 
intensity 
from 
strain 
KS7669 
+LMB 
LFQ 
Ratio  
Peptides 
from 
strain 
KS7669-
LMB 
Peptides 
from 
strain 
KS7669 
+LMB 
LFQ 
intensity 
from 
strain 
KS7669 
-LMB 
LFQ 
intensity 
from 
strain 
KS7669 
+LMB 
LFQ 
Ratio  
Alp7 20 13 2.5e8 1.4e8 1.7 14 15 6.3e8 4.4e8 1.4 
Crm1 17 4 1.1e8 1.3e7 9.0 19 3 2.9e8 6.8e6 43.3 
Mto1 59 58 2.6e11 2.9e11 0.9 58 59 6.1e11 6.7e11 0.9 
Mto2 7 7 2.0e8 2.2e8 0.9 5 5 6.5e8 8.4e8 0.8 
Nsp1 7 7 6.9e7 6.0e7 1.2 11 11 3.7e8 3.7e8 1.0 
Nup146 14 8 7.4e7 3.3e7 2.3 12 5 1.9e8 5.6e7 3.4 
Nup82 9 10 4.5e7 7.6e7 0.6 9 9 1.7e8 2.9e8 0.6 
Plo1 26 26 2.4e8 2.4e8 1.0 25 27 8.5e8 7.7e8 1.1 
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 1377 
  1378 
 38 
Table 3 1379 
Data for selected proteins from mass spectrometry comparison of GFP-Mto1[9A1-NE]-1380 
HTB and GFP-Mto1[∆NES-9A1-NE]-HTB interactomes. 1381 
Peptide counts and label-free quantification (LFQ) values for selected proteins shown in Fig. 1382 
4D. Data from two independent biological replicates are shown. See also Supplementary 1383 
File 5. 1384 
 1385 
Protein 
Replicate 1 (E160419) Replicate 2 ((E161127) 
Peptides 
from 
strain 
KS7611 
Peptides 
from 
strain 
KS8573 
LFQ 
intensity 
from 
strain 
KS7611 
LFQ 
intensity 
from 
strain 
KS8573 
LFQ 
Ratio  
Peptides 
from 
strain 
KS7611 
Peptides 
from 
strain 
KS8573 
LFQ 
intensity 
from 
strain 
KS7611 
LFQ 
intensity 
from 
strain 
KS8573 
LFQ 
Ratio  
Alp7 15 14 2.2e8 1.4e8 1.5 12 9 2.1e8 1.4e8 1.5 
Crm1 21 2 2.9e8 3.4e6 85.2 20 2 3.5e8 5.5e6 63.4 
Mto1 47 47 3.1e11 3.2e11 1.0 40 40 3.1e11 3.2e11 1.0 
Mto2 10 10 4.8e9 4.1e9 1.2 8 8 6.3e9 5.9e9 1.1 
Nsp1 10 9 2.2e8 1.2e8 1.8 10 9 2.4e8 1.0e8 2.4 
Nup146 15 3 2.0e8 9.5e6 20.7 19 0 1.5e8 NQ NQ 
Nup82 10 7 8.1e7 2.2e7 3.7 6 2 5.1e7 NQ NQ 
Plo1 17 15 2.5e8 1.6e8 1.5 17 10 2.2e8 1.8e8 1.2 
 1386 
NQ = not quantified, because peptide count and/or LFQ intensity in the relevant samples 1387 
was below threshold for quantification. 1388 
 1389 
 1390 
 1391 
Table 4 1392 
Data for selected proteins from mass spectrometry comparison of GFP-Mto1[9A1-NE]-1393 
HTB interactomes in wild-type (nup146+) and nup146[∆FG5-12] cells. 1394 
Peptide counts and label-free quantification (LFQ) values for selected proteins from the two 1395 
replicate experiments contributing to the graph in Fig. 6F. Complete datasets are in 1396 
Supplementary File 6. 1397 
 1398 
Protei
n 
Replicate 1 (E170214) Replicate 2 (E170306) 
Peptide
s from 
strain 
KS9021 
Peptide
s from 
strain 
KS9077 
LFQ 
intensit
y from 
strain 
KS9021 
LFQ 
intensit
y from 
strain 
KS9077 
LFQ 
Ratio 
Peptide
s from 
strain 
KS9021 
Peptide
s from 
strain 
KS9077 
LFQ 
intensit
y from 
strain 
KS9021 
LFQ 
intensit
y from 
strain 
KS9077 
LFQ 
Ratio 
Alp7 17 15 1.4e8 1.4e8 1.0 16 16 1.0e8 8.2e7 1.3 
Crm1 31 17 3.4e8 9.2e7 3.6 27 18 1.7e8 6.1e7 2.9 
Mto1 62 61 2.7e11 2.6e11 1.0 55 54 1.7e11 1.8e11 0.9 
Mto2 12 12 6.0e9 5.0e9 1.2 13 13 3.8e9 3.1e9 1.2 
Nsp1 11 3 8.3e7 2.7e7 3.0 9 4 3.5e7 1.7e7 2.1 
Nup14
6 29 6 2.1e8 1.5e7 13.9 31 10 1.4e8 1.5e7 9.2 
Nup82 13 10 1.1e8 4.0e7 2.8 12 11 4.9e7 2.5e7 2.0 
Plo1 17 17 1.5e8 1.3e8 1.1 17 17 1.1e8 8.1e7 1.3 
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FIGURE LEGENDS 1401 
 1402 
Figure 1. Identification of proteins interacting with Mto1[NE] but not Mto[bonsai]. 1403 
(A) Diagram of full-length Mto1 and Mto1-truncation mutants. Asterisk indicates 9A1 1404 
mutation, which abolishes interaction with -tubulin complex (Samejima et al., 2008, PMID 1405 
19001497). (B) Outline of cross-linking and mass spectrometry approach to identify Mto1 1406 
interactors. (C) Localization of GFP-Mto1[9A1-NE]-HTB and GFP-Mto1[9A1-bonsai]-HTB. 1407 
Numbers below images indicate percent cells with GFP signal on the nuclear envelope (n= 1408 
total number of cells scored). (D) Anti-Mto1 Western blot of whole-cell lysates from GFP-1409 
mto1[9A1-NE]-HTB cells in the absence of cross-linking (-DSS) and after disuccinimidyl 1410 
suberate cross-linking (+DSS). Dashed line indicates boundary between resolving gel and 1411 
stacking gel. (E) SDS-PAGE of GFP-Mto1[9A1-NE]-HTB sample and GFP-Mto1[9A1-1412 
bonsai]-HTB sample after DSS cross-linking and two-step denaturing purification. Regions 1413 
marked “X-linked” were analyzed by mass spectrometry (see Materials and Methods). (F) 1414 
Mass spectrometry label-free quantification (LFQ) of 750 proteins from samples as in E. 1415 
“LFQ ratio” indicates relative enrichment of a given protein in the purified GFP-Mto1[9A1-1416 
NE]-HTB sample compared to the purified GFP-Mto1[9A1-bonsai]-HTB sample. “LFQ 1417 
intensity” indicates total intensity (arbitrary units) of a given protein from the combined 1418 
purified samples . Data shown represent one of two independent biological replicates. See 1419 
also Table 1. Complete datasets are in Supplementary File 3. Bar, 5 µm. 1420 
 1421 
Figure 1—figure supplement 1. Nuclear positioning in mto1 mutants. 1422 
Nuclear positioning in strains of the indicated genotypes (see Fig. 1A). 100 cells of each 1423 
genotype were scored. For each cell, distance from nucleus to each cell end was measured. 1424 
The shorter of the two distances was termed S, and the longer was termed L. Y-axis shows 1425 
ratio S/L for cells of each genotype, in rank order. Higher S/L ratios indicate more accurate 1426 
nuclear centering. * p<0.01; ** p<0.001 (non-paired t-test, two-tailed); other differences are 1427 
not significant. Actual p values are: mto1-GFP vs. mto1[NE]-GFP, 0.99; mto1-GFP vs. 1428 
mto1[∆130]-GFP, 0.0066; mto1-GFP vs. mto1[bonsai]-GFP, 0.0002; mto1[NE]-GFP vs. 1429 
mto1[∆130]-GFP, 0.0060; mto1[NE]-GFP vs. mto1[bonsai]-GFP, 0.0002; mto1[∆130]-GFP 1430 
vs. mto1[bonsai]-GFP, 0.29. 1431 
 1432 
Figure 1—figure supplement 2. The mto1 9A1 mutation enhances Mto1[NE]-GFP 1433 
localization to the nuclear envelope. 1434 
Both Mto1[NE]-GFP and Mto1[bonsai]-GFP promote microtubule (MT) nucleation by the -1435 
tubulin complex, and thus both are present at minus ends of individual MTs within MT 1436 
bundles, even though neither binds directly to the MT lattice. When the 9A1 mutation is 1437 
introduced into Mto1, absence of MT nucleation abrogates association with MT minus ends, 1438 
leading to increased Mto1[9A1-NE]-GFP on the nuclear envelope (previously described by 1439 
Lynch et al., 2014, PMID 24704079). Bar, 5 µm. 1440 
 1441 
Figure 1—figure supplement 3. Alp7 is not required for Mto1[NE] localization to the 1442 
nuclear envelope. 1443 
Localization of Mto1[9A1-NE]-GFP to the nuclear envelope (NE) in wild-type (alp7+) and 1444 
alp7∆ cells. Numbers below images indicate percent cells with Mto1[9A1-NE]-GFP on the 1445 
NE (n= total number of cells scored). Bar, 5 µm. 1446 
 1447 
Figure 2. Mto1[NE] is localized to the cytoplasmic face of the nuclear pore complex. 1448 
(A) Colocalization of Mto1[9A1-NE]-GFP and Nup146-3mCherry after nuclear pore complex 1449 
(NPC) clustering in nup132∆ cells. For each cell, a single central Z-section is shown. (B) 1450 
Immunoelectron microscopy of Mto1[9A1-NE]-GFP. Left panel shows cross-section of a 1451 
single cell. NPCs can be seen as slightly electron-dense regions where inner and outer 1452 
nuclear membranes meet. Yellow arrowheads indicate NPCs with Mto1[9A1-NE]-GFP on 1453 
cytoplasmic face of NPC. White arrowheads indicate examples of unstained NPCs. Right 1454 
panels show magnified examples from other cells. Blue and yellow dots indicate inner and 1455 
 40 
outer nuclear membranes, respectively. N, nucleus; C, cytoplasm; m, mitochondria. Bars, 5 1456 
µm (A), 0.5 µm (B). 1457 
 1458 
Figure 3. Inhibition of Crm1 cargo-binding by Leptomycin B treatment disrupts 1459 
Mto1[NE] localization to nuclear pore complexes and Mto1[NE] interaction with Crm1. 1460 
(A) Localization of Nup146-3mCherry and Mto1[9A1-NE]-GFP in untreated cells and in cells 1461 
treated with 1% ethanol (+EtOH) or with 100 nM leptomycin B (+LMB) in ethanol for 15 min. 1462 
Numbers below images indicate percent cells with Mto1 on NPCs (n=total number of cells 1463 
scored). (B) Localization of Nup146-3mCherry and Mto1[9A1-NE]-GFP in crm1-C529A cells, 1464 
which are resistant to LMB. Cells were untreated or treated with 100 nM LMB for 15 or 60 1465 
min. (C) Mass spectrometry label-free quantification (LFQ) of 483 proteins from samples of 1466 
cross-linked, purified GFP-Mto1[9A1-NE]-HTB from untreated (”minusLMB”) vs. LMB-treated 1467 
(”plusLMB”) cells. “LFQ ratio” indicates relative enrichment of a given protein in the purified 1468 
minusLMB sample compared to the purified plusLMB sample. “LFQ intensity” indicates total 1469 
intensity (arbitrary units) of a given protein from the combined purified samples. Data shown 1470 
represent geometric mean from two independent biological replicates. See also Table 2. 1471 
Complete datasets are in Supplementary File 4. Bars, 5 µm. 1472 
 1473 
Figure 3—figure supplement 1. Leptomycin B treatment leads to accumulation of Alp7 1474 
in the nucleoplasm. 1475 
Localization of Nup146-3mCherry and Alp7-3GFP in untreated cells and in cells treated with 1476 
1% ethanol (+EtOH; carrier) or with 100 nM leptomycin B (LMB) in ethanol for 15 and 45 1477 
min. Numbers below images indicate percent cells with Alp7 in the nucleus (n=total number 1478 
of cells scored). Arrowheads indicate examples of Alp7-3GFP accumulation in the nucleus. 1479 
Brackets indicate examples of Alp7-3GFP puncta on an intranuclear microtubule bundle that 1480 
can form in interphase cells after LMB treatment (Matsuyama et al., 2006, PMID 16823372). 1481 
Bar, 5 µm. 1482 
 1483 
Figure 3—figure supplement 2. Characterization of crm1-C529 mutants. 1484 
(A) Growth of wild-type (crm1+) cells and the crm1 mutants indicated, on plates with and 1485 
without leptomycin B (LMB). The crm1-C529A, crm1-C529T, and crm1-C529V mutants are 1486 
essentially completely resistant to LMB, while the crm1-C529S mutant is only partially 1487 
resistant. (B) Mto1[9A1-NE]-GFP and Nup146-3mCherry localization in the crm1 mutants 1488 
indicated, in the absence of LMB. In crm1-C529S, crm1-C529T, and crm1-C529V mutants, 1489 
Mto1[9A1-NE]-GFP fails to localize to nuclear pore complexes (NPCs), although it does 1490 
localize to NPCs in crm1-C529A mutants (Fig. 3). Bar, 5 µm. 1491 
 1492 
Figure 3—figure supplement 3. Microtubule regrowth after leptomycin B treatment. 1493 
Anti-tubulin immunofluorescence of control (ethanol-treated) and leptomycin B (LMB)-treated 1494 
cells during microtubule (MT) regrowth after cold-induced MT depolymerization, in a strain 1495 
expressing untagged, full-length wild-type Mto1. Arrowheads indicate examples of MT 1496 
regrowth from the nuclear envelope, which does not occur in LMB-treated cells. MT regrowth 1497 
is slightly slower in LMB-treated cells compared to control cells, possibly because LMB leads 1498 
to increased intranuclear localization of some MT-associated proteins, such as Alp7 (see 1499 
Fig. 3--figure supplement 1). LMB treatment also leads to partial intranuclear localization of 1500 
tubulin after cold treatment, although this may be only a small proportion of total tubulin, as 1501 
most MT regrowth in LMB-treated cells still occurs in the cytoplasm. 1502 
 1503 
Figure 4. Mto1 interacts with Crm1 via a NES-like sequence near the Mto1 amino-1504 
terminus. 1505 
(A) Predicted NESs in the first 33 amino acids of Mto1, with associated LocNES scores (Xu 1506 
et al., 2015, PMID 25515756). These are the only sequences in the first 130 amino acids of 1507 
Mto1 with LocNES scores greater than 0.1 (B) Alignment of Mto1 amino acids 12-25 with 1508 
four non-natural, high-affinity NESs (“supraphysiological” NESs) described by Güttler et al. 1509 
(Güttler et al., 2010, PMID 20972448; Engelsma et al., 2004, PMID 15329671). Conserved 1510 
 41 
hydrophic residues are indicated in red. Acidic residues shown to enhance NES affinity for 1511 
Crm1 are in blue. (C) Localization of GFP-Mto1[9A1-NE]-HTB and GFP-Mto1[∆NES-9A1-1512 
NE]-HTB, which lacks Mto1 amino acids 1-25. Numbers below images indicate percent cells 1513 
with Mto1 at NPCs (n= total number of cells scored). (D) Mass spectrometry label-free 1514 
quantification (LFQ) of 469 proteins from samples of cross-linked, purified GFP-Mto1[9A1-1515 
NE]-HTB (”WT”) and cross-linked, purified GFP-Mto1[∆NES-9A1-NE]-HTB (”∆NES”). “LFQ 1516 
ratio” indicates relative enrichment of a given protein in the purified WT sample compared to 1517 
the purified ∆NES sample. “LFQ intensity” indicates total intensity (arbitrary units) of a given 1518 
protein from the combined purified samples. Data shown represent one of two independent 1519 
biological replicates. Nup82 is labeled because it is likely to interact with Nup146, based on 1520 
homology with budding yeast (Belgareh et al., 1998, PMID 9843582). See also Table 3. 1521 
Complete datasets are in Supplementary File 5. (E) Localization of the indicated Mto1 1522 
fragments fused to GFP at their N-termini and either GST or 13Myc at their C-termini. 1523 
Arrowheads indicate examples of localization to the NPCs. Numbers below images indicate 1524 
percent cells with Mto1 at NPCs (n= total number of cells scored). (F) Localization of GFP-1525 
Mto1[1-29]-GST in leptomycin B-treated cells. Images in E and F are single Z-sections, while 1526 
other images are maximum projections. Bars, 5 µm. 1527 
 1528 
Figure 5. Expression of dominant-negative Ran (spi1[T23N]) but not constitutively 1529 
active Ran (spi1[Q68L]) disrupts localization of Mto1[NE] to nuclear pore complexes. 1530 
Mto1[9A1-NE]-GFP localization in strains containing different versions of Ran (spi1 in fission 1531 
yeast) expressed from the thiamine-repressible nmt41 promoter, together with control wild-1532 
type cells (spi1+). Cells are shown in the presence of thiamine (+Thi), and 26 and 34 h after 1533 
removal of thiamine (-Thi). 26 and 34 h represent early and later stages of induced 1534 
expression, respectively (see Fig. 5—figure supplement 2). Numbers below images indicate 1535 
percent cells with Mto1[9A1-NE]-GFP on nuclear pore complexes (n=total number of cells 1536 
scored). Bar, 5 µm. 1537 
 1538 
Figure 5—figure supplement 1. Effects of mutant Ran (spi1 in fission yeast) on cell 1539 
viability. 1540 
Colony formation after 2 d growth in the presence and absence of thiamine, in wild-type 1541 
control cells (spi1+) and in cells expressing transgenes for wild-type Ran (nmt41:spi1+), 1542 
dominant-negative Ran (nmt41:spi1[T23N]), or constitutively-active Ran (nmt41:spi1[Q68L]), 1543 
under the control of the medium-strength thiamine-repressible nmt41 promoter. 1544 
 1545 
Figure 5—figure supplement 2. Effects of mutant Ran (spi1 in fission yeast) on 1546 
Mto1[NE] localization to nuclear pore complexes and on import of a nuclear 1547 
localization signal (NLS) reporter. 1548 
Localization of Mto1[9A1-NE]-GFP, together with nuclear-localization-signal (NLS) reporter 1549 
GST-NLS-mCherry, in wild-type control cells (spi1+) and in cells expressing transgenes for 1550 
wild-type Ran (nmt41:spi1+), dominant-negative Ran (nmt41:spi1[T23N]), or constitutively-1551 
active Ran (nmt41:spi1[Q68L]), under the control of the medium-strength thiamine-1552 
repressible nmt41 promoter. Cells are shown in the presence of thiamine (+Thi), and 26 and 1553 
34 h after removal of thiamine to induce expression (-Thi). GST-NLS-mCherry expression is 1554 
under control of the low-strength thiamine-repressible nmt81 promoter and is therefore also 1555 
induced after removal of thiamine. As a result, GST-NLS-mCherry reports both the kinetics 1556 
of thiamine-regulated expression (e.g. 26 vs. 34 h) and the effects of different Ran mutants 1557 
on nuclear transport and/or nuclear morphology. Numbers below images indicate percent 1558 
cells with Mto1[9A1-NE]-GFP on nuclear pore complexes (NPCs; green), and percent cells 1559 
with GST-NLS-mCherry in the nucleus (N; red). n=total number of cells scored. Images of 1560 
GST-NLS-mCherry are sum projections, while images of Mto1[9A1-NE]-GFP are maximum 1561 
projections. Bar, 5 µm. 1562 
 1563 
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Figure 6. Nup146 FG repeats are required for Mto1[NE] docking at nuclear pore 1564 
complexes, microtubule nucleation from the nuclear envelope region, and Mto1 1565 
interaction with Nup146. 1566 
(A) Diagram of Nup146 and Nup146[∆FG5-12]. (B) Localization of Mto1[9A1-NE]-GFP in 1567 
wild-type (nup146+) and nup146[∆FG5-12] cells. Numbers below images indicate percent 1568 
cells with Mto1 on NPCs (n= total number of cells scored). (C) Anti-tubulin 1569 
immunofluorescence of wild-type (nup146+) and nup146[∆FG5-12] cells during microtubule 1570 
(MT) regrowth after cold-induced MT depolymerization. Both strains express full-length, wild-1571 
type Mto1. Arrowheads in nup146+ cells indicate examples of MT regrowth from the nuclear 1572 
envelope (NE), which does not occur in nup146[∆FG5-12] cells. (D) GFP-tubulin images 1573 
from time-lapse video showing MT nucleation in wild-type (nup146+) and nup146[∆FG5-12] 1574 
cells. Yellow dashed line indicates cell nucleus. Red arrowheads indicate nucleation from 1575 
the NE region. Blue arrowhead indicates nucleation from non-NE cytoplasmic region. In 1576 
these cells, Mto1[NE] is also tagged with GFP but is too faint to be seen relative to GFP-1577 
tubulin. (E) Quantification of MT nucleation from videos of the type shown in D. Numbers 1578 
represent total number of events for 90 cells of each strain, imaged for 100 s. Differences 1579 
between strains were highly significant (p=0.0026; Fisher’s exact test, two-sided). (F) Mass 1580 
spectrometry label-free quantification (LFQ) of 512 proteins from samples of cross-linked, 1581 
purified GFP-Mto1[9A1-NE]-HTB from wild-type (nup146+) and from nup146[∆FG5-12] cells. 1582 
“LFQ ratio” indicates relative enrichment of a given protein in the purified sample from 1583 
nup146+ cells compared to the purified sample from nup146[∆FG5-12] cells. “LFQ intensity” 1584 
indicates total intensity (arbitrary units) of a given protein from the combined purified 1585 
samples. Data shown represent geometric mean from two independent biological replicates. 1586 
Nup82 and Nsp1 are labeled because they are likely to interact with Nup146, based on 1587 
homology with budding yeast (Belgareh et al., 1998, PMID 9843582). See also Table 4. 1588 
Complete datasets are in Supplementary File 6.  Bars, 5 µm. 1589 
 1590 
Figure 6—figure supplement 1. Additional characterization of Nup146[∆FG5-12]. 1591 
(A) Diagram of S. pombe Nup146 (see Fig. 6), together with homologs S. cerevisiae Nup159 1592 
and H. sapiens Nup214. Note rearranged domain organization in Nup214. All FG (Phe-Gly) 1593 
sequence repeats are numbered, although some (e.g. near N-terminus) may not interact 1594 
with nuclear transport receptors. Where FG repeats are densely distributed, the 1595 
corresponding region is labeled. Asterisks in Nup214 indicate structured portion of FG 1596 
repeats observed in co-crystal with Crm1 (Port et al., 2015, PMID 26489467). Beta-propeller 1597 
structures in Sc Nup159 and Hs Nup214 have been experimentally verified (Weirich et al., 1598 
2004, PMID 15574330; Napetschnig et al., 2007, PMID 17264208) and bind to RNA 1599 
helicases Sc Dbp5 and Hs Ddx19 (respectively), which are involved in mRNP processing in 1600 
terminal stages of mRNA export. Beta-propeller structure in Nup146 is predicted (Weirich et 1601 
al. 2004). Alpha-helical regions were predicted using JPred4 (Drozdetskiy et al., 2015, PMID 1602 
25883141). Thicker lines in alpha-helical regions indicate predicted coiled-coils or 1603 
amphipathic helices. Alpha-helix at the C-terminus of Sc Nup159 is involved in forming a 1604 
heterotrimeric complex with Sc Nup82 and Sc Nup116 (Yoshida et al., 2011, PMID 1605 
21930948), whose counterparts in fission yeast are Nup82 and Nup189n, respectively. (B) 1606 
Localization of Nup146[∆FG5-12]-3mCherry to NPCs, with corresponding localization of 1607 
Mto1[9A1-NE]-GFP. 1608 
 1609 
Fig. 7 Model for Mto1/2 complex docking at the nuclear pore complex (NPC), 1610 
compared to conventional nuclear export 1611 
(A) Conventional export cargos form a trimeric complex with Crm1 and RanGTP in the 1612 
nucleus. Passage through NPC permeability barrier depends on interaction of export 1613 
complexes with FG repeats of symmetric FG-Nups. While passing through the NPC, some 1614 
export complexes may also interact with FG repeats of Nup146 (not shown). Once in the 1615 
cytoplasm, export complexes are disassembled by soluble RanBP1 and RanGAP, and 1616 
RanGTP is hydrolyzed to RanGDP (here, multiple steps are simplified to a single step). (B) 1617 
Mto1/2 complex docked at NPC. Mto1/2 is sourced from a cytoplasmic pool rather than a 1618 
 43 
nucleoplasmic pool. The Mto1 NES-M binds Crm1 by mimicking an export cargo, and the 1619 
docking complex binds to cytoplasmic FG-Nup Nup146. Docking requires RanGTP and FG 1620 
repeats of Nup146. See also Figure 7—figure supplement 1. 1621 
 1622 
Figure 7—figure supplement 1. Models for stable docking of a high-affinity NES cargo 1623 
at the cytoplasmic face of the nuclear pore complex via Nup146 and for formation of 1624 
export-like complexes from cytoplasmic cargo. 1625 
(A) Speculative model for how a high-affinity NES cargo could become docked at the 1626 
cytoplasmic face of the nuclear pore complex (NPC). In diagrams, only the FG-repeat region 1627 
of Nup146 is shown; by analogy to Sc Nup159, Nup146 is assumed to be anchored at the 1628 
cytoplasmic face of the NPC by interaction of its C-terminal domain with partners Nup82 and 1629 
Nsp1. Binding of Crm1 to cargo, RanGTP and Nup146 FG repeats all contribute 1630 
cooperatively to Crm1 compact conformation. Therefore, 1) if cargo has only low affinity for 1631 
Crm1, then after partial release of Nup146 FG repeats from Crm1, the trimeric export 1632 
complex (Crm1, cargo and RanGTP) can disassemble, releasing cargo into the cytoplasm. 1633 
However, 2) if cargo has a high affinity for Crm1, then stabilization of the Crm1 compact 1634 
conformation by cargo binding allows partially released FG repeats to rebind to Crm1. 1635 
Increased stability of interaction between trimeric complex and Nup146 FG repeats leads to 1636 
increased residence time at the cytoplasmic face of the NPC. See main text for further 1637 
details. (B) “Cargo-handover” as a potential mechanism for incorporating high-affinity NES 1638 
cargos from the cytoplasm into export-like complexes at the cytoplasmic face of NPCs. First, 1639 
a conventional nuclear export complex with a low-affinity NES cargo transiently interacts 1640 
with Nup146 FG repeats during passage through the NPC. Recent integrated structural 1641 
analysis in budding yeast suggests that FG repeats of Sc Nup159 may be directly adjacent 1642 
to the symmetric FG-Nups at the centre of the NPC (Fernandez-Martinez et al., 2016, PMID 1643 
27839866); therefore, even though Nup146 FG repeats are not required for export, some 1644 
proportion of export complexes could be expected to interact with Nup146 during passage 1645 
through the NPC. Second, low-affinity cargo dissociates from Crm1, while Crm1 remains 1646 
bound to Nup146 and to RanGTP. Dissociation of low-affinity cargo could be either 1647 
spontaneous or aided by RanBP1; in both cases this could occur without dissociation or 1648 
hydrolysis of RanGTP (Koyama et al. 2010, PMID 27839866). In absence of cargo, compact 1649 
Crm1 conformation (and RanGTP binding) may be partially stabilized by interaction with 1650 
Nup146 FG repeats, as has been shown for FG repeats of Hs Nup214 (Hutten et al,. 2006, 1651 
PMID 16943420).  Finally, during a “window of opportunity” before dissociation of Crm1 from 1652 
Nup146, a high-affinity NES cargo such as the Mto1 NES-M can bind to Crm1 to generate 1653 
the export-like complex. 1654 
 1655 
 1656 
SUPPLEMENTARY FILES 1657 
 1658 
Supplementary File 1. Yeast strains, plasmids and oligonucleotides used in this work. 1659 
 1660 
Supplementary File 2. Mass spectrometry data and summary from preliminary SILAC 1661 
experiment. 1662 
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Supplementary File 3. Combined mass spectrometry data and LFQ summaries for 1664 
experiments shown in Fig. 1. 1665 
 1666 
Supplementary File 4. Combined mass spectrometry data and LFQ summaries for 1667 
experiments shown in Fig. 3. 1668 
 1669 
Supplementary File 5. Combined mass spectrometry data and LFQ summaries for 1670 
experiments shown in Fig. 4. 1671 
 1672 
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Supplementary File 6. Combined mass spectrometry data and LFQ summaries for 1673 
experiments shown in Fig. 6. 1674 
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Figure 1. Identification of proteins interacting with Mto1[NE] but not Mto[bonsai].
(A) Diagram of full-length Mto1 and Mto1-truncation mutants. Asterisk indicates 9A1 mutation, which abolishes interaction 
with g-tubulin complex (Samejima et al., 2008, PMID 19001497). (B) Outline of cross-linking and mass spectrometry 
approach to identify Mto1 interactors. (C) Localization of GFP-Mto1[9A1-NE]-HTB and GFP-Mto1[9A1-bonsai]-HTB. Num-
bers below images indicate percent cells with GFP signal on the nuclear envelope (n= total number of cells scored). (D) 
Anti-Mto1 Western blot of whole-cell lysates from GFP-mto1[9A1-NE]-HTB cells in the absence of cross-linking (-DSS) and 
after disuccinimidyl suberate cross-linking (+DSS). Dashed line indicates boundary between resolving gel and stacking 
gel. (E) SDS-PAGE of GFP-Mto1[9A1-NE]-HTB sample and GFP-Mto1[9A1-bonsai]-HTB sample after DSS cross-linking 
and two-step denaturing purification. Regions marked “X-linked” were analyzed by mass spectrometry (see Materials and 
Methods). (F) Mass spectrometry label-free quantification (LFQ) of 750 proteins from samples as in E. “LFQ ratio” in-
dicates relative enrichment of a given protein in the purified GFP-Mto1[9A1-NE]-HTB sample compared to the purified 
GFP-Mto1[9A1-bonsai]-HTB sample. “LFQ intensity” indicates total intensity (arbitrary units) of a given protein from the 
combined purified samples . Data shown represent one of two independent biological replicates. See also Table 1. 
Complete datasets are in Supplementary File 3. Bar, 5 µm. 
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Figure 1--figure supplement 1. Nuclear positioning in mto1 mutants.
Nuclear positioning in strains of the indicated genotypes (see Fig. 1A). 100 cells of each genotype were scored. For each 
cell, distance from nucleus to each cell end was measured. The shorter of the two distances was termed S, and the longer 
was termed L. Y-axis shows ratio S/L for cells of each genotype, in rank order. Higher S/L ratios indicate more accurate 
nuclear centering. * p<0.01; ** p<0.001 (non-paired t-test, two-tailed); other differences are not significant. Actual p values 
are: mto1-GFP vs. mto1[NE]-GFP, 0.99; mto1-GFP vs. mto1[∆130]-GFP, 0.0066; mto1-GFP vs. mto1[bonsai]-GFP, 
0.0002; mto1[NE]-GFP vs. mto1[∆130]-GFP, 0.0060; mto1[NE]-GFP vs. mto1[bonsai]-GFP, 0.0002; mto1[∆130]-GFP vs. 
mto1[bonsai]-GFP, 0.29.
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Figure 1--figure supplement 2. The mto1 9A1 mutation enhances Mto1[NE]-GFP 
localization to the nuclear envelope.
Both Mto1[NE]-GFP and Mto1[bonsai]-GFP promote microtubule (MT) nucleation by the 
g-tubulin complex, and thus both are present at minus ends of individual MTs within MT 
bundles, even though neither binds directly to the MT lattice. When the 9A1 mutation is 
introduced into Mto1, absence of MT nucleation abrogates association with MT minus ends, 
leading to increased Mto1[9A1-NE]-GFP on the nuclear envelope (previously described by 
Lynch et al., 2014, PMID 24704079). Bar, 5 µm.
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Figure 1--figure supplement 3. Alp7 is not required for Mto1[NE] localization to 
the nuclear envelope.
Localization of Mto1[9A1-NE]-GFP to the nuclear envelope (NE) in wild-type (alp7+) 
and alp7∆ cells. Numbers below images indicate percent cells with 
Mto1[9A1-NE]-GFP on the NE (n= total number of cells scored). Bar, 5 µm.
Mto1[9A1-NE]-GFP
alp7+
95% on NE (n=114)
alp7∆
88% (n=137)
Mto1[9A1-NE]-
GFP
Mto1[9A1-NE]-GFPNup146-
3mCherry merge
A B
Figure 2. Mto1[NE] is localized to the cytoplasmic face of the nuclear pore complex.
(A) Colocalization of Mto1[9A1-NE]-GFP and Nup146-3mCherry after nuclear pore complex (NPC) clustering in nup132∆ cells. 
For each cell, a single central Z-section is shown. (B) Immunoelectron microscopy of Mto1[9A1-NE]-GFP. Left panel shows 
cross-section of a single cell. NPCs can be seen as slightly electron-dense regions where inner and outer nuclear membranes 
meet. Yellow arrowheads indicate NPCs with Mto1[9A1-NE]-GFP on cytoplasmic face of NPC. White arrowheads indicate 
examples of unstained NPCs. Right panels show magnified examples from other cells. Blue and yellow dots indicate inner and 
outer nuclear membranes, respectively. N, nucleus; C, cytoplasm; m, mitochondria. Bars, 5 µm (A), 0.5 µm (B).
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Figure 3. Inhibition of Crm1 cargo-binding by Leptomycin B treatment disrupts Mto1[NE] localization to nuclear 
pore complexes and Mto1[NE] interaction with Crm1.
(A) Localization of Nup146-3mCherry and Mto1[9A1-NE]-GFP in untreated cells and in cells treated with 1% ethanol 
(+EtOH) or with 100 nM leptomycin B (+LMB) in ethanol for 15 min. Numbers below images indicate percent cells with Mto1 
on NPCs (n=total number of cells scored). (B) Localization of Nup146-3mCherry and Mto1[9A1-NE]-GFP in crm1-C529A 
cells, which are resistant to LMB. Cells were untreated or treated with 100 nM LMB for 15 or 60 min. (C) Mass spectrome-
try label-free quantification (LFQ) of 483 proteins from samples of cross-linked, purified GFP-Mto1[9A1-NE]-HTB from 
untreated (”minusLMB”) vs. LMB-treated (”plusLMB”) cells. “LFQ ratio” indicates relative enrichment of a given protein 
in the purified minusLMB sample compared to the purified plusLMB sample. “LFQ intensity” indicates total intensity 
(arbitrary units) of a given protein from the combined purified samples. Data shown represent geometric mean from 
two independent biological replicates. See also Table 2. Complete datasets are in Supplementary File 4. Bars, 5 µm. 
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Figure 3--figure supplement 1. Leptomycin B treatment leads to accumulation of 
Alp7 in the nucleoplasm.
Localization of Nup146-3mCherry and Alp7-3GFP in untreated cells and in cells treated 
with 1% ethanol (+EtOH; carrier) or with 100 nM leptomycin B (LMB) in ethanol for 15 and 
45 min. Numbers below images indicate percent cells with Alp7 in the nucleus (n=total 
number of cells scored). Arrowheads indicate examples of Alp7-3GFP accumulation in the 
nucleus. Brackets indicate examples of Alp7-3GFP puncta on an intranuclear microtubule 
bundle that can form in interphase cells after LMB treatment (Matsuyama et al., 2006, 
PMID 16823372). Bar, 5 µm.
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Figure 3--figure supplement 2. Characterization of crm1-C529 mutants.
(A) Growth of wild-type (crm1+) cells and the crm1 mutants indicated, on plates with and without lepto-
mycin B (LMB). The crm1-C529A, crm1-C529T, and crm1-C529V mutants are essentially completely 
resistant to LMB, while the crm1-C529S mutant is only partially resistant. (B) Mto1[9A1-NE]-GFP and 
Nup146-3mCherry localization in the crm1 mutants indicated, in the absence of LMB. In crm1-C529S, 
crm1-C529T, and crm1-C529V mutants, Mto1[9A1-NE]-GFP fails to localize to nuclear pore complexes 
(NPCs), although it does localize to NPCs in crm1-C529A mutants (Fig. 3). Bar, 5 µm.
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Figure 3--figure supplement 3. Microtubule regrowth after leptomycin B treatment.
Anti-tubulin immunofluorescence of control (ethanol-treated) and leptomycin B (LMB)-treated cells during 
microtubule (MT) regrowth after cold-induced MT depolymerization, in a strain expressing untagged, 
full-length wild-type Mto1. Arrowheads indicate examples of MT regrowth from the nuclear envelope, 
which does not occur in LMB-treated cells. MT regrowth is slightly slower in LMB-treated cells com-
pared to control cells, possibly because LMB leads to increased intranuclear localization of some 
MT-associated proteins, such as Alp7 (see Fig. 3--figure supplement 1). LMB treatment also leads to 
partial intranuclear localization of tubulin after cold treatment, although this may be only a small 
proportion of total tubulin, as most MT regrowth in LMB-treated cells still occurs in the cytoplasm.
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Figure 4. Mto1 interacts with Crm1 via a NES-like sequence near the Mto1 amino-terminus.
(A) Predicted NESs in the first 33 amino acids of Mto1, with associated LocNES scores (Xu et al., 2015, PMID 25515756). 
These are the only sequences in the first 130 amino acids of Mto1 with LocNES scores greater than 0.1 (B) Alignment of 
Mto1 amino acids 12-25 with four non-natural, high-affinity NESs (“supraphysiological” NESs) described by Güttler et al. 
(Güttler et al., 2010, PMID 20972448; Engelsma et al., 2004, PMID 15329671). Conserved hydrophic residues are indicat-
ed in red. Acidic residues shown to enhance NES affinity for Crm1 are in blue. (C) Localization of GFP-Mto1[9A1-NE]-HTB 
and GFP-Mto1[∆NES-9A1-NE]-HTB, which lacks Mto1 amino acids 1-25. Numbers below images indicate percent cells 
with Mto1 at NPCs (n= total number of cells scored). (D) Mass spectrometry label-free quantification (LFQ) of 469 
proteins from samples of cross-linked, purified GFP-Mto1[9A1-NE]-HTB (”WT”) and cross-linked, purified GFP-Mto1[∆
NES-9A1-NE]-HTB (”∆NES”). “LFQ ratio” indicates relative enrichment of a given protein in the purified WT sample 
compared to the purified ∆NES sample. “LFQ intensity” indicates total intensity (arbitrary units) of a given protein 
from the combined purified samples. Data shown represent one of two independent biological replicates. Nup82 is 
labeled because it is likely to interact with Nup146, based on homology with budding yeast (Belgareh et al., 1998, 
PMID 9843582). See also Table 3. Complete datasets are in Supplementary File 5. (E) Localization of the indicated 
Mto1 fragments fused to GFP at their N-termini and either GST or 13Myc at their C-termini. Arrowheads indicate examples 
of localization to the NPCs. Numbers below images indicate percent cells with Mto1 at NPCs (n= total number of cells 
scored). (F) Localization of GFP-Mto1[1-29]-GST in leptomycin B-treated cells. Images in E and F are single Z-sections, 
while other images are maximum projections. Bars, 5 µm.
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Figure 5. Expression of dominant-negative Ran (spi1[T23N]) but not constitutively active Ran (spi1[Q68L]) disrupts 
localization of Mto1[NE] to nuclear pore complexes.
Mto1[9A1-NE]-GFP localization in strains containing different versions of Ran (spi1 in fission yeast) expressed from the thia-
mine-repressible nmt41 promoter, together with control wild-type cells (spi1+). Cells are shown in the presence of thiamine 
(+Thi), and 26 and 34 h after removal of thiamine (-Thi). 26 and 34 h represent early and later stages of induced expression, 
respectively (see Fig. 5--figure supplement 2). Numbers below images indicate percent cells with Mto1[9A1-NE]-GFP on 
nuclear pore complexes (n=total number of cells scored). Bar, 5 µm. 
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Figure 5--figure supplement 1. Effects of mutant Ran (spi1 in fission yeast) on cell viability.
Colony formation after 2 d growth in the presence and absence of thiamine, in wild-type control 
cells (spi1+) and in cells expressing transgenes for wild-type Ran (nmt41:spi1+), dominant-negative 
Ran (nmt41:spi1[T23N]), or constitutively-active Ran (nmt41:spi1[Q68L]), under the control of the 
medium-strength thiamine-repressible nmt41 promoter.
Figure 5--figure supplement 2. Effects of mutant Ran (spi1 in fission yeast) on Mto1[NE] localization to 
nuclear pore complexes and on import of a nuclear localization signal (NLS) reporter.
Localization of Mto1[9A1-NE]-GFP, together with nuclear-localization-signal (NLS) reporter GST-NLS-mCherry, in 
wild-type control cells (spi1+) and in cells expressing transgenes for wild-type Ran (nmt41:spi1+), dominant-negative 
Ran (nmt41:spi1[T23N]), or constitutively-active Ran (nmt41:spi1[Q68L]), under the control of the medium-strength 
thiamine-repressible nmt41 promoter. Cells are shown in the presence of thiamine (+Thi), and 26 and 34 h after 
removal of thiamine to induce expression (-Thi). GST-NLS-mCherry expression is under control of the low-strength 
thiamine-repressible nmt81 promoter and is therefore also induced after removal of thiamine. As a result, 
GST-NLS-mCherry reports both the kinetics of thiamine-regulated expression (e.g. 26 vs. 34 h) and the effects of 
different Ran mutants on nuclear transport and/or nuclear morphology. Numbers below images indicate percent 
cells with Mto1[9A1-NE]-GFP on nuclear pore complexes (NPCs; green), and percent cells with GST-NLS-mCherry 
in the nucleus (N; red). n=total number of cells scored. Images of GST-NLS-mCherry are sum projections, while 
images of Mto1[9A1-NE]-GFP are maximum projections. Bar, 5 µm. 
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Figure 6. Nup146 FG repeats are required for Mto1[NE] docking at nuclear pore complexes, microtubule nucleation 
from the nuclear envelope region, and Mto1 interaction with Nup146.
(A) Diagram of Nup146 and Nup146[∆FG5-12]. (B) Localization of Mto1[9A1-NE]-GFP in wild-type (nup146+) and 
nup146[∆FG5-12] cells. Numbers below images indicate percent cells with Mto1 on NPCs (n= total number of cells 
scored). (C) Anti-tubulin immunofluorescence of wild-type (nup146+) and nup146[∆FG5-12] cells during microtubule 
(MT) regrowth after cold-induced MT depolymerization. Both strains express full-length, wild-type Mto1. Arrowheads 
in nup146+ cells indicate examples of MT regrowth from the nuclear envelope (NE), which does not occur in 
nup146[∆FG5-12] cells. (D) GFP-tubulin images from time-lapse video showing MT nucleation in wild-type (nup146+) 
and nup146[∆FG5-12] cells. Yellow dashed line indicates cell nucleus. Red arrowheads indicate nucleation from 
the NE region. Blue arrowhead indicates nucleation from non-NE cytoplasmic region. In these cells, Mto1[NE] is also 
tagged with GFP but is too faint to be seen relative to GFP-tubulin. (E) Quantification of MT nucleation from videos 
of the type shown in D. Numbers represent total number of events for 90 cells of each strain, imaged for 100 s. 
Differences between strains were highly significant (p=0.0026; Fisher’s exact test, two-sided). (F) Mass spectrometry 
label-free quantification (LFQ) of 512 proteins from samples of cross-linked, purified GFP-Mto1[9A1-NE]-HTB from 
wild-type (nup146+) and from nup146[∆FG5-12] cells. “LFQ ratio” indicates relative enrichment of a given protein in 
the purified sample from nup146+ cells compared to the purified sample from nup146[∆FG5-12] cells. “LFQ intensity” 
indicates total intensity (arbitrary units) of a given protein from the combined purified samples. Data shown represent 
geometric mean from two independent biological replicates. Nup82 and Nsp1 are labeled because they are likely to 
interact with Nup146, based on homology with budding yeast (Belgareh et al., 1998, PMID 9843582). See also Table 
4. Complete datasets are in Supplementary File 6.  Bars, 5 µm.
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Figure 6--figure supplement 1. Additional characterization of Nup146[∆FG5-12].
(A) Diagram of S. pombe Nup146 (see Fig. 6), together with homologs S. cerevisiae Nup159 and H. sapi-
ens Nup214. Note rearranged domain organization in Nup214. All FG (Phe-Gly) sequence repeats are 
numbered, although some (e.g. near N-terminus) may not interact with nuclear transport receptors. Where 
FG repeats are densely distributed, the corresponding region is labeled. Asterisks in Nup214 indicate 
structured portion of FG repeats observed in co-crystal with Crm1 (Port et al., 2015, PMID 26489467). 
Beta-propeller structures in Sc Nup159 and Hs Nup214 have been experimentally verified (Weirich et al., 
2004, PMID 15574330; Napetschnig et al., 2007, PMID 17264208) and bind to RNA helicases Sc Dbp5 
and Hs Ddx19 (respectively), which are involved in mRNP processing in terminal stages of mRNA export. 
Beta-propeller structure in Nup146 is predicted (Weirich et al. 2004). Alpha-helical regions were predicted 
using JPred4 (Drozdetskiy et al., 2015, PMID 25883141). Thicker lines in alpha-helical regions indicate 
predicted coiled-coils or amphipathic helices. Alpha-helix at the C-terminus of Sc Nup159 is involved in 
forming a heterotrimeric complex with Sc Nup82 and Sc Nup116 (Yoshida et al., 2011, PMID 21930948), 
whose counterparts in fission yeast are Nup82 and Nup189n, respectively. (B) Localization of Nup146[∆
FG5-12]-3mCherry to NPCs, with corresponding localization of Mto1[9A1-NE]-GFP.
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Fig. 7 Model for Mto1/2 complex docking at the nuclear pore complex (NPC), compared to conventional 
nuclear export
(A) Conventional export cargos form a trimeric complex with Crm1 and RanGTP in the nucleus. Passage through 
NPC permeability barrier depends on interaction of export complexes with FG repeats of symmetric FG-Nups. 
While passing through the NPC, some export complexes may also interact with FG repeats of Nup146 (not shown). 
Once in the cytoplasm, export complexes are disassembled by soluble RanBP1 and RanGAP, and RanGTP is 
hydrolyzed to RanGDP (here, multiple steps are simplified to a single step). (B) Mto1/2 complex docked at NPC. 
Mto1/2 is sourced from a cytoplasmic pool rather than a nucleoplasmic pool. The Mto1 NES-M binds Crm1 by 
mimicking an export cargo, and the docking complex binds to cytoplasmic FG-Nup Nup146. Docking requires 
RanGTP and FG repeats of Nup146. See also Figure 7--figure supplement 1.
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Figure 7--figure supplement 1. Models for stable docking of a high-affinity NES cargo at the cytoplasmic face 
of the nuclear pore complex via Nup146 and for formation of export-like complexes from cytoplasmic cargo.
(A) Speculative model for how a high-affinity NES cargo could become docked at the cytoplasmic face of the nuclear 
pore complex (NPC). In diagrams, only the FG-repeat region of Nup146 is shown; by analogy to Sc Nup159, Nup146 
is assumed to be anchored at the cytoplasmic face of the NPC by interaction of its C-terminal domain with partners 
Nup82 and Nsp1. Binding of Crm1 to cargo, RanGTP and Nup146 FG repeats all contribute cooperatively to Crm1 
compact conformation. Therefore, 1) if cargo has only low affinity for Crm1, then after partial release of Nup146 FG 
repeats from Crm1, the trimeric export complex (Crm1, cargo and RanGTP) can disassemble, releasing cargo into the 
cytoplasm. However, 2) if cargo has a high affinity for Crm1, then stabilization of the Crm1 compact conformation by 
cargo binding allows partially released FG repeats to rebind to Crm1. Increased stability of interaction between trimeric 
complex and Nup146 FG repeats leads to increased residence time at the cytoplasmic face of the NPC. See main text 
for further details. (B) “Cargo-handover” as a potential mechanism for incorporating high-affinity NES cargos from the 
cytoplasm into export-like complexes at the cytoplasmic face of NPCs. First, a conventional nuclear export complex 
with a low-affinity NES cargo transiently interacts with Nup146 FG repeats during passage through the NPC. Recent 
integrated structural analysis in budding yeast suggests that FG repeats of Sc Nup159 may be directly adjacent to 
the symmetric FG-Nups at the centre of the NPC (Fernandez-Martinez et al., 2016, PMID 27839866); therefore, even 
though Nup146 FG repeats are not required for export, some proportion of export complexes could be expected to 
interact with Nup146 during passage through the NPC. Second, low-affinity cargo dissociates from Crm1, while Crm1 
remains bound to Nup146 and to RanGTP. Dissociation of low-affinity cargo could be either spontaneous or aided 
by RanBP1; in both cases this could occur without dissociation or hydrolysis of RanGTP (Koyama et al. 2010, PMID 
27839866). In absence of cargo, compact Crm1 conformation (and RanGTP binding) may be partially stabilized by 
interaction with Nup146 FG repeats, as has been shown for FG repeats of Hs Nup214 (Hutten et al,. 2006, PMID 
16943420).  Finally, during a “window of opportunity” before dissociation of Crm1 from Nup146, a high-affinity NES 
cargo such as the Mto1 NES-M can bind to Crm1 to generate the export-like complex.
